Rokk3r (ROKK) 10-K 1 Apr 19 2018 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2018	Mar. 22, 2019	Jun. 29, 2018
Document and Entity Information
Entity Registrant Name	ROKK3R INC.
Entity Central Index Key	0001100778
Document Type	10-K
Entity Trading Symbol	edrg
Document Period End Date	Dec. 31, 2018
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Public Float			$ 16,541,938
Entity Common Stock, Shares Outstanding		101,427,105
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2018
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Shell Company	false

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2018	Dec. 31, 2017
CURRENT ASSETS:
Cash	$ 2,297,902
Accounts receivable, net	400,182
Prepaid expenses - related party	425,000
Prepaid expenses	18,953
Receivable from parent company	75,138
Total Current Assets	3,217,175
Furniture and equipment, net	19,015
Investment in parent company - cost method	1,000,000	1,000,000
Total Assets	4,236,190	1,000,000
CURRENT LIABILITIES:
Accounts payable	192,225	40,619
Accrued expenses	18,407	21,244
Accrued expenses - related party	15,000
Deferred revenue	20,000
Convertible note payable, net		540,000
Notes payable - other	12,000	12,000
Due to parent company		16,492
Total Current Liabilities	257,632	630,355
SHAREHOLDERS' EQUITY:
Common stock - $0.0001 par value; 500,000,000 shares authorized; 101,427,105 and 94,828,287 shares issued and outstanding at December 31, 2018 and 2017, respectively	10,143	9,483
Common stock issuable; 1,000,000 and nil shares issuable at December 31, 2018 and 2017	100
Additional paid in capital	76,217,441	71,814,487
Accumulated deficit	(74,968,545)	(71,454,325)
Total Shareholders' Equity	1,259,139	369,645
Total Liabilities and Shareholders' Equity	4,236,190	1,000,000
Series A Non-Convertible Preferred Stock [Member]
SHAREHOLDERS' EQUITY:
Preferred stock value
Series B Convertible Preferred Stock [Member]
Redeemable Preferred Stock:
Convertible preferred stock	$ 2,719,419

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2018	Dec. 31, 2017
SHAREHOLDERS' EQUITY
Preferred Stock, par value	$ 0.0001	$ 0.0001
Preferred Stock, shares authorized	50,000,000	50,000,000
Common Stock, par value	$ 0.0001	$ 0.0001
Common Stock, shares authorized	500,000,000	500,000,000
Common Stock, shares issued	101,427,105	94,828,287
Common Stock, shares outstanding	101,427,105	94,828,287
Common Stock, Shares issuable	1,000,000	0
Series A Non-Convertible Preferred Stock [Member]
SHAREHOLDERS' EQUITY
Preferred Stock, par value	$ 0.0001	$ 0.0001
Preferred Stock, shares authorized	1,000,000	1,000,000
Preferred Stock, shares issued	0	0
Preferred Stock, shares outstanding	0	0
Series B Convertible Preferred Stock [Member]
SHAREHOLDERS' EQUITY
Preferred Stock, par value	$ 0.0001	$ 0.0001
Preferred Stock, shares authorized	4,687,500	4,687,500
Preferred Stock, shares issued	4,085,938	0
Preferred Stock, shares outstanding	4,085,938	0
Preferred Stock, liquidation preference	$ 2,719,419	$ 2,719,419

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Consolidated Statements Of Operations
Revenues	$ 2,301,939
Operating Expenses:
Consulting fees - parent	2,701,250
Consulting fees - other	529,432	13,449,969
Compensation expense	505,943	12,687,607
Contract labor	770,887
Legal expense	385,859	72,305
Professional fees	243,955	51,435
Bad debt expense	148,982	5,784
General and administrative expenses	383,434	439,073
Impairment loss		12,489,226
Total Operating Expenses	5,669,742	39,195,399
Loss from Operations	(3,367,803)	(39,195,399)
Other Income (Expense):
Gain on extinguishment of debt (Note 1)		1,889,938
Interest expense	(40,993)	(592,824)
Other expense	(1,005)
Total Other Income (Expense)	(41,998)	1,297,114
Loss Before Provision for Income Taxes	(3,409,801)	(37,898,285)
Provision for income taxes
Net loss	$ (3,409,801)	$ (37,898,285)
Net Loss per Share of Common Stock Outstanding - Basic and Diluted	$ (0.03)	$ (1.39)
Weighted-average number of shares outstanding - Basic and Diluted	99,662,397	27,267,239

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)	Preferred Stock	Common Stock	Common Stock Issuable [Member]	Additional paid-in capital	Accumulated deficit	Total
Beginning balance, Shares at Dec. 31, 2016		362,200
Beginning balance, Amount at Dec. 31, 2016		$ 36		$ 31,690,302	$ (33,556,040)	$ (1,865,702)
Series A Preferred stock issued to officer for services rendered, Shares	1,000,000	9,710,295
Series A Preferred stock issued to officer for services rendered, Amount	$ 37,500	$ 971		12,428,207		12,466,678
Common stock issued to consultants for services rendered or to be rendered, Shares		16,518,108
Common stock issued to consultants for services rendered or to be rendered, Amount		$ 1,652		21,141,526		21,143,178
Cancellation of Series A Preferred stock issued to officer pursuant to restructuring agreement, Shares	(1,000,000)	(10,000,795)
Cancellation of Series A Preferred stock issued to officer pursuant to restructuring agreement, Amount	$ (37,500)	$ (1,000)		38,500
Cancellation of stock previously issued in exchange for consulting services pursuant to restructuring agreement, Shares		(15,860,295)
Cancellation of stock previously issued in exchange for consulting services pursuant to restructuring agreement, Amount		$ (1,586)		(7,870,414)		(7,872,000)
Common stock issued to purchase investment in Rock3r Labs, LLC, Shares		9,677,208
Common stock issued to purchase investment in Rock3r Labs, LLC, Amount		$ 968		12,385,858		12,386,826
Common stock issued upon conversion of debt, Shares		1,355,783
Common stock issued upon conversion of debt, Amount		$ 135		1,517,665		1,517,800
Common stock issued to convertible debt holders pursuant to restructuring agreement, Shares		1,185,783
Common stock issued to convertible debt holders pursuant to restructuring agreement, Amount		$ 119		(119)
Common stock issued for convertible debt financing, Shares		250,000
Common stock issued for convertible debt financing, Amount		$ 25		319,975		320,000
Common stock issued for investment in Protect Pharmaceutical Solutions, Shares		3,000,000
Common stock issued for investment in Protect Pharmaceutical Solutions, Amount		$ 300		3,839,700		3,840,000
Cancellation of common stock issued for investments in Protect Pharmaceutical Solutions pursuant to restructuring agreement, Shares		(3,000,000)
Cancellation of common stock issued for investments in Protect Pharmaceutical Solutions pursuant to restructuring agreement, Amount		$ (300)		(3,839,700)		(3,840,000)
Common stock issued for purchase of Park Road Solutions, Shares		80,000
Common stock issued for purchase of Park Road Solutions, Amount		$ 8		102,392		102,400
Common stock issued for settlement of default and release with Rokk3r Fuel Fund 2, LP pursuant to restructuring agreement, Shares		7,500,000
Common stock issued for settlement of default and release with Rokk3r Fuel Fund 2, LP pursuant to restructuring agreement, Amount		$ 750		68,000		68,750
Common stock issued for contribution of intangible assets to Rokk3r Labs, LLC pursuant to restructuring agreement, Shares		74,050,000
Common stock issued for contribution of intangible assets to Rokk3r Labs, LLC pursuant to restructuring agreement, Amount		$ 7,405		(7,405)
Net loss					(37,898,285)	(37,898,285)
Ending balance, Shares at Dec. 31, 2017		94,828,287
Ending balance, Amount at Dec. 31, 2017		$ 9,483		71,814,487	(71,454,325)	369,645
Common stock issued upon conversion of debt, Shares		750,000
Common stock issued upon conversion of debt, Amount		$ 75		482,473		482,548
Common stock issued for cash to investors pursuant to subscription agreements, Shares		5,836,532
Common stock issued for cash to investors pursuant to subscription agreements, Amount		$ 584		3,734,796		3,735,380
Common stock issued to consultants for services, Shares		12,286
Common stock issued to consultants for services, Amount		$ 1		25,799		25,800
Stock-based compensation				49,986		49,986
Common stock issuable in connection with stock-based compensation, Shares
Common stock issuable in connection with stock-based compensation, Amount			1,000,000	100	(100)
Reclassification of note premium upon debt conversion				110,000		110,000
Series B Preferred stock redemption premium					(104,419)	(104,419)
Net loss					(3,409,801)	(3,409,801)
Ending balance, Shares at Dec. 31, 2018		101,427,105	1,000,000
Ending balance, Amount at Dec. 31, 2018		$ 10,143	$ 100	$ 76,217,441	$ (74,968,545)	$ 1,259,139

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Cash Flows from Operating Activities:
Net loss	$ (3,409,801)	$ (37,898,285)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	1,608
Gain on the extinguishment of debt		(1,889,938)
Stock-based compensation	49,986
Common stock issued for compensation and consulting services	25,800	25,737,856
Common stock issued for settlement pursuant to restructuring agreement		68,750
Impairment loss		12,489,226
Non-cash interest expense	40,994	560,000
Bad debt	148,982	5,784
Change in operating assets and liabilities:
Accounts receivable	(549,164)	(5,784)
Receivable from affliate	(75,138)
Prepaid expenses	(443,953)
Accounts payable	151,606	52,619
Deferred revenue	20,000
Accrued expense	23,717	13,369
Due to parent company		16,492
Accrued interest payable - related party		19,506
Net cash used in operating activities	(4,015,363)	(830,405)
Cash Flows from Investing Activities:
Investment in Rock3r Labs, LLC		(1,000,000)
Purchases of property and equipment	(20,623)
Net cash used in investing activities	(20,623)	(1,000,000)
Cash Flows from Financing Activities:
Proceeds from parent advances	(16,492)	12,605
Cash proceeds from notes payable		1,517,800
Proceeds from convertible note payable		300,000
Cash proceeds from sale of common stock	3,735,380
Cash proceeds from sale of Series B convertible preferred shares	2,615,000
Net cash provided by financing activities	6,333,888	1,830,405
Increase in Cash	2,297,902
Cash at beginning of year
Cash at end of year	2,297,902
Supplemental Disclosure of Interest and Income Taxes Paid:
Interest paid
Income taxes paid
Supplemental schedule of non-cash investing and financing activities
Stock issued for debt conversion	482,548	1,517,800
Reclassification of note premium upon conversion of debt	110,000
Stock issued for acquisition of Park Road Solutions		102,400
Stock issued to purchase interest in Rock3r Labs, LLC		12,386,826
Common stock issued for settlement pursuant to restructuring agreement		68,750
Accounts payable converted to note payable		$ 12,000

ORGANIZATION AND DESCRIPTION OF

ORGANIZATION AND DESCRIPTION OF BUSINESS	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS	Rokk3r Inc. (the “Company”), formerly known as Eight Dragons Company, is a Nevada corporation. Its predecessor was incorporated in Delaware on September 27, 1996. On March 23, 2018, we changed our name to Rokk3r Inc. in order to reflect our current business of providing consulting services and related value generating strategies. The name change (the “Name Change”) was effected through a parent-subsidiary short-form merger between the Company and its wholly owned subsidiary, Rokk3r Inc., a Nevada corporation pursuant to Nevada Revised Statutes 92A.180. In connection with theName Change, on June 18, 2018, our trading symbol was changed to “ROKK” and our CUSIP No. to 77544L104. The Name Change was done to reflect its current business of providing consulting services and related value generating strategies which it commenced following the recently acquired technology platform to partner with entrepreneurs, strategists, creatives and engineers to design, build and launch organizations. The Company commenced this line of business following completion of the transactions set forth in the restructuring agreement and related transactions discussed below. On October 24, 2007, the Company changed its state of incorporation from Delaware to Nevada by means of a merger with and into Eight Dragons Company solely for the purpose of effecting the reincorporation. Effective March 20, 2017, DMJ Acquisitions LLC, the former principal stockholder of the Company (“DMJ”), entered into a Stock Purchase Agreement (the “Agreement”) dated January 26, 2017, with Una Taylor through Eight Dragons Acquisitions, LLC, an entity she controls (the “Buyer”), pursuant to which, among other things, DMJ agreed to sell to the Buyer, and the Buyer agreed to purchase from DMJ, a total of 290,500 shares of common stock owned of record and beneficially by DMJ (the “Purchased Shares”). The Purchased Shares represented, at closing, approximately 80.2% of the Company’s issued and outstanding shares of common stock. The funds for the acquisition were provided by the parent company controlled by the former Chief Executive Officer of the Company and used for the benefit of the Buyer, the Company’s former Chief Executive Officer, controls. In connection with the transactions contemplated by the Agreement, the liabilities of Eight Dragons were forgiven and the Board of Directors appointed Una Taylor and Theodore Faison to fill vacancies on the Company’s Board of Directors, and the prior director resigned. The forgiven stockholder liabilities totaled $1,889,938, including $1,037,632 in principal and $852,406 in accrued interest, which has been reflected as a gain on extinguishment of debt on the accompanying statement of operations for the year ended December 31, 2017. On December 26, 2017, the Company entered into a restructuring agreement (the “Restructuring Agreement”) with Una Taylor, the former Chief Executive Officer and substantial stockholder of the Company, and Rokk3r Labs LLC (“Rokk3r Labs”). The Restructuring Agreement provided for certain transactions as described below. The transactions contemplated by the Restructuring Agreement (the “Transactions”) closed on December 26, 2017 (the “Closing Date”). As a result of the closing of the Transactions (the “Closing”), Rokk3r Labs acquired control of the Company from Ms. Taylor. Following the Closing, Rokk3r Labs owns 89.41% of the Company’s outstanding shares of common stock and the Company became a majority-owned subsidiary of Rokk3r Labs. The following transactions were completed on the Closing Date in conjunction and as conditions to the Closing: • · The Company and Eight Dragons Acquisition, LLC (“Eight Dragons LLC”), an affiliate of Ms. Taylor, rescinded certain transactions between the Company and Eight Dragons LLC, and in connection therewith Eight Dragons LLC returned to the Company 290,500 shares of common stock, for no additional consideration. • The Company and Ms. Taylor rescinded certain transactions between the Company and Ms. Taylor, and in connection therewith Ms. Taylor returned to the Company 9,710,295 shares of common stock and 1,000,000 shares of preferred stock, par value $0.0001 per share, of the Company, for no additional consideration. In connection therewith, the Company and Ms. Taylor entered into the Taylor Rescission Agreement. • Pursuant to an Asset and Intellectual Property Contribution and Assignment Agreement entered into between the Company and Rokk3r Labs dated December 26, 2017 (the “Contribution and Assignment Agreement”), Rokk3r Labs contributed to the capital of the Company certain intellectual property assets of Rokk3r Labs in exchange for the issuance to Rokk3r Labs of 74,050,000 shares of unregistered common stock. The Contribution and Assignment Agreement was entered into as one of the conditions to the Restructuring Agreement. Pursuant to the terms of the Restructuring Agreement, Ms. Taylor and Theodore Faison resigned from all positions with the Company held by them effective as of the Closing Date. In addition, the Company appointed to the Board of Directors Nabyl Charania, German Montoya and Jeff Ransdell appointed Mr. Charania as the Chief Executive Officer and Principal Accounting Officer of the Company. In connection with the Restructuring Agreement, the Company, Rokk3r Labs and Ms. Taylor also entered into a release agreement , pursuant to which each party released the others and each of their respective predecessors, successors, assigns, heirs, representatives, agents and all related parties from all claims of any type that any such party may have had or may have in the future, to the extent that those claims arose, may have arisen, or are based on events which occurred at any point in the past up to and including December 26, 2017, other than any claims arising from the Restructuring Agreement. On May 10, 2018, the Board of Directors approved the incorporation of two wholly-owned subsidiaries, Rokk3r Ops Inc. to provide our "Think Phase", "Co-build", and “Scale” services; and Rokk3r Fluid Inc. to pursue our plans to launch our newly created blockchain consulting services division. Both entities were incorporated in Florida. Rokk3r Ops Inc. is fully operational, and its financials are already consolidated. Rokk3r Fluid Inc. is not operational yet as of the December 31, 2018. On October 15, 2018, the Board of Directors of Rokk3r Ops Inc., Company’s wholly-owned subsidiary, approved the incorporation of two wholly-owned subsidiaries, B3riblock Inc., to develop a blockchain-based document safeguarding, authentication and tracking platform, and Rokk3r Flamingo Inc. Both entities were incorporated in Delaware, and neither is operational as of December 31, 2018. On November 20, 2018, the Board of Directors of Rokk3r Ops Inc., Company’s wholly-owned subsidiary, approved the incorporation of Rokk3r Ai Inc., to conduct some business of the Corporation consisting of helping enterprises to evolve from collecting data to understanding and using it, through the creation and management of large-scale enterprise knowledge graphs. Rokk3r Ai Inc. is not operational yet as of the December 31, 2018.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Basis of Presentation and Principles of Consolidation The consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (“US GAAP”)and present the consolidated financial statements of the Company and its wholly-owned subsidiaries of which all are inactive except for Rokk3r Ops Inc. All intercompany balances and transactions have been eliminated in the consolidation. Use of Estimates The preparation of the consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates for the years ended December 31, 2018 and 2017 include the assumptions used in assessing impairment of investments, allowances on uncollectible accounts receivable, valuation allowances for deferred tax assets, and the fair value of the account receivable, non-cash equity transactions and stock-based compensation. Cash and Cash Equivalents For the purposes of the consolidated statements of cash flows, the Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents at December 31, 2018 and 2017, respectively. The Company maintained its cash in various financial institutions during the year ended December 31, 2018. Balances were insured up to Federal Deposit Insurance Corporation limits. Accounts Receivable Accounts receivable are stated at their net realizable value. The Company reviews its accounts to estimate losses resulting from the inability of its customer to make required payments. Any required allowance is based on specific analysis of past due accounts and considers historical trends if write-offs. Past due is based on how recently payments have been received from customers. The Company’s collection experience has been favorable reflecting a limited number of customers. As of December 31, 2018, the recorded allowance for bad debt was $148,982 and no allowance was recorded at December 31, 2017. Revenue Recognition In accordance with Accounting Standards Codification (“ASC”) 606, Revenue Recognition, The services that are offered are focused on education, consulting, development and growth. The Company provides services to help entrepreneurs and business professionals to innovate and create high growth companies through training, mentorship, and access to our global network of advisors, investors and business builders. Revenue is recognized when the Company performs services pursuant to its agreements with customers and collectability is reasonably assured. If at the outset of an arrangement, the Company determines that collectability is not reasonably assured, revenue is deferred until the earlier of when collectability becomes probable or the receipt of payment. If there is uncertainty as to the customer’s acceptance of the Company’s deliverables, revenue is not recognized until the earlier of receipt of customer acceptance or expiration of the acceptance period. If at the outset of an arrangement, the Company determines that the arrangement fee is not fixed or determinable, revenue is deferred until the arrangement fee becomes estimable, assuming all other revenue recognition criteria have been met. Litigation settlements are accounted for in accordance with the gain contingency provisions of ASC Subtopic 450-30, Gain Contingencies Fair Value of Financial Instruments ASC 825, Disclosures about Fair Value of Financial Instruments Fair Value Measurements The carrying amounts reported in the balance sheets for accounts receivable, prepaid expenses, accounts payable, accrued expenses, convertible note payable, note payable and amounts due to parent company approximate their fair market value based on the short-term maturity of these instruments. Investments The method of accounting applied to long-term investments, whether consolidated, equity or cost, involves an evaluation of the significant terms of each investment that explicitly grant or suggest evidence of control or influence over the operations of the investee and also includes the identification of any variable interests in which the Company is the primary beneficiary. Investments in businesses that the Company does not control, but in which the Company has the ability to exercise significant influence over operating and financial matters, are accounted for using the equity method. Investments in which the Company does not have the ability to exercise significant influence over operating and financial matters are accounted for using the cost method. Equity and cost method investments are included “Investments” in the accompanying balance sheets. The Company periodically evaluates its equity and cost method investments for impairment due to declines considered to be other than temporary. If the Company determines that a decline in fair value is other than temporary, then a charge to earnings is recorded as an impairment loss in the accompanying statements of operations. Based on an impairment analysis, during the years ended December 31, 2018 and 2017, the Company recorded an impairment loss of nil and $12,489,226, respectively, related to investments with has been included in operating expenses on the accompanying statement of operations (see Note 5). Convertible Notes with Fixed Rate Conversion Options The Company may enter into convertible notes, some of which contain, predominantly, fixed rate conversion features, whereby the outstanding principal and accrued interest may be converted by the holder, into common shares at a fixed discount to the market price of the common stock at the time of conversion. This results in a fair value of the convertible note being equal to a fixed monetary amount. The Company records the convertible note liability at its fixed monetary amount by measuring and recording a premium, as applicable, on the Note date with a charge to interest expense in accordance with ASC 480 - Distinguishing Liabilities from Equity Convertible Debt In July 2017, the FASB issued Accounting Standards Update (“ASU”) No. 2017-11 Earnings Per Share Distinguishing Liabilities from Equity Derivatives and Hedging Redeemable Preferred Stock Redeemable preferred stock (i.e., redeemable upon the occurrence of an event) and preferred stock that is redeemable (outside the control of the issuer), including those instruments that are redeemable at the option of the holder, are required to be present in mezzanine equity. Mezzanine equity is presented after liabilities and before stockholders’ equity on the balance sheet. The purpose of this classification is to convey that such a security may not be permanently part of equity and could result in a demand for cash or other assets of the entity in the future. Pursuant to ASC 480-10-S99, the Company presents redeemable securities that are classified as mezzanine equity separate from all other stockholders’ equity accounts that are classified as permanent equity (e.g., non-redeemable preferred, common stock, and retained earnings). The Company sold 4,085,938 shares of Series B Preferred for net proceeds of $2,615,000, or $0.64 per preferred share, during the year ended December 31, 2018 which is classified in mezzanine equity under “Redeemable Preferred Stock” (see Note 7). Basic Loss per Common Share Basic loss per share is calculated by dividing the net loss allocable to stockholders by the weighted-average number of shares outstanding for the period. Diluted loss per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that shared in the earnings (loss) of the Company. Diluted loss per share is computed by dividing the net loss allocable to stockholders by the weighted average number of shares outstanding for the period and dilutive potential shares outstanding unless such dilutive potential shares would result in anti-dilution. As of December 31, 2018, and 2017, potentially dilutive securities consisted of the following: December 31, 2018 2017 Convertible debt $ — $ 430,000 Stock-Based Compensation Stock-based compensation is accounted for based on the requirements of ASC 718 – “Compensation –Stock Compensation, ), Improvements to Employee Share-Based Payment Accounting Through March 31, 2018, pursuant to ASC 505-50 – “Equity-Based Payments to Non-Employees ” Improvements to Nonemployee Share-Based Payment Accounting, Segment Reporting During the years ended December 31, 2018 and 2017, the Company operated in one business segment. Recent Accounting Pronouncements In November 2018, the FASB issued ASU 2018-18— Collaborative Arrangements 1. Clarify that certain transactions between collaborative arrangement participants should be accounted for as revenue under Topic 606 when the collaborative arrangement participant is a customer in the context of a unit of account. In those situations, all the guidance in Topic 606 should be applied, including recognition, measurement, presentation, and disclosure requirements. 2. Add unit-of-account guidance in Topic 808 to align with the guidance in Topic 606 (that is, a distinct good or service) when an entity is assessing whether the collaborative arrangement or a part of the arrangement is within the scope of Topic 606. 3. Require that in a transaction with a collaborative arrangement participant that is not directly related to sales to third parties, presenting the transaction together with revenue recognized under Topic 606 is precluded if the collaborative arrangement participant is not a customer For public business entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2020, and interim periods within fiscal years beginning after December 15, 2021. Early adoption is permitted, including adoption in any interim period, (1) for public business entities for periods for which financial statements have not yet been issued and (2) for all other entities for periods for which financial statements have not yet been made available for issuance. An entity may not adopt the amendments earlier than its adoption date of Topic 606. The amendments in this Update should be applied retrospectively to the date of initial application of Topic 606. An entity should recognize the cumulative effect of initially applying the amendments as an adjustment to the opening balance of retained earnings of the later of the earliest annual period presented and the annual period that includes the date of the entity’s initial application of Topic 606. An entity may elect to apply the amendments in this Update retrospectively either to all contracts or only to contracts that are not completed at the date of initial application of Topic 606. An entity should disclose its election. An entity may elect to apply the practical expedient for contract modifications that is permitted for entities using the modified retrospective transition method in Topic 606. The Company is currently evaluating the effect on its consolidated financial statements. In February 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-02, Leases Reclassifications The Company segregated the legal and bad debt expenses for year ended December 31, 2018 in separate line items in the operating expense section of the accompanying consolidatedstatement of operations and conformed the presentation of the same for the year ended December 31, 2017 for comparative presentation.

GOING CONCERN

GOING CONCERN	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
NOTE 3 - GOING CONCERN	These consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying consolidated financial statements, the Company had a net loss of $3,409,801 for year ended December 31, 2018. The net cash used in operations was $4,015,363 for the year ended December 31, 2018. Additionally, the Company had an accumulated deficit of $74,968,545, and had stockholders’ equity of $1,259,139 at December 31, 2018. During the year ended December 31, 2018, the Company sold its common stock for net proceeds of $3,735,380 and Series B Preferred (as defined in Note 7) for net proceeds of $2,615,000 for total net proceeds of $6,350,380. The Company had a cash balance of $2,297,902 at December 31, 2018. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for twelve months from the issuance date of this report. The Company’s controlling shareholder, Rokk3r Labs LLC (“Rokk3r Labs”), has committed to meeting its operating expenses. Management cannot provide assurance that the Company will ultimately achieve profitable operations or become cash flow positive, or raise additional debt and/or equity capital. These consolidated financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

PREPAID EXPENSE

PREPAID EXPENSE	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
NOTE 4 – PREPAID EXPENSE	Prepaid expenses consisted of the following as of December 31, 2018 and 2017: December 31, 2018 2017 Related party – prepaid consulting fee pursuant to Consulting Services Agreement with ExO $ 250,000 $ — Related party – prepaid consulting fee – parent 175,000 Other 18,953 — $ 443,953 $ —

INVESTMENTS

INVESTMENTS	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
NOTE 5 - INVESTMENTS	On April 30, 2017, the Company completed a purchase of a non-controlling 18.72% membership interest in Rokk3r Labs for a purchase price of $1,000,000 (provided at the direction of an entity controlled by Una Taylor for the benefit of the Company) and the issuance of 9,677,208 shares of its common stock valued at $12,386,826 or $1.28 per share. Rokk3r Labs is a venture builder and operator of a ‘co-building’ platform for entrepreneurs, corporations and investors to create exponential startups. As a result of the closing of the transactions (see Note 1), Rokk3r Labs acquired control of the Company from Ms. Taylor. Following the Closing, Rokk3r Labs owned 89.41% of the Company’s outstanding shares of common stock. Accordingly, the Company became a majority-owned subsidiary of Rokk3r Labs. In connection with the Transactions and recapitalization of the Company, in December 2017, the Company wrote down its investment in Rokk3r Labs to $1,000,000 to reflect the cash purchase price. Accordingly, during the year ended December 31, 2017, the Company recorded an impairment loss of $12,386,826, which amount is attributable to the Company’s common stock issued to Rokk3r Labs. At December 31, 2018 and 2017, the Company’s cost method investment in Rokk3r Labs amounted to $1,000,000. On June 30, 2017, as consideration for 6,100,000 shares of Protect Pharmaceutical Corporation (“PRTT”), the Company issued 3,000,000 shares of its common stock to PRTT valued at $3,840,000 or $1.28 per common share. This investment was made to establish a strategic partnership which is intended to provide financial exits for portfolio companies of the Company. On November 19, 2017, the Company and PRTT entered into a Rescission and Mutual Release Agreement (the “PRTT Rescission Agreement”), pursuant to which the parties rescinded certain transactions between them, and in connection therewith PRTT returned to the Company 3,000,000 shares of its common stock, and the Company returned to PRTT 6,100,000 shares of common stock of PRTT that the Company had acquired in the transactions, and the parties each released each other from any claims one may have had against the other. In June 2017, the Company issued 80,000 shares of its common stock for an investment in Park Road Solutions. The Company valued these shares at $102,400, or $1.28 per common share. During the year ended December 31, 2017, based on an impairment analysis, the Company wrote off its investment and recorded an impairment loss of $102,400. During years ended December 31, 2018 and 2017, the Company recorded nil and $12,489,226 of impairment loss, respectively, related to investments.

CONVERTIBLE PROMISSORY NOTE

CONVERTIBLE PROMISSORY NOTE	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
NOTE 6 - CONVERTIBLE PROMISSORY NOTE	On April 27, 2017, the Company entered into Securities Purchase Agreements with Firstfire Global Opportunities Fund, LLC (“Firstfire”) for the sale of a convertible promissory note in aggregate principal amount of $330,000 (the “Firstfire Note”). The Firstfire Note was due on October 27, 2017, bears interest of 1% per annum and provides that the Company issue Firstfire 250,000 shares of common stock as additional consideration for the purchase of the Firstfire Note. Any principal amount or interest on this Note not paid when due shall bear interest at the rate of 15% per annum from the due date thereof until paid in full. In the event that the Company fails to pay the principal amount hereof or interest thereon in full on the maturity date, the Company shall be obligated to pay Firstfire an additional $100,000 penalty. The Firstfire Note was convertible into common stock, at Firstfire’s option, at 75% multiplied by the lowest traded price of the Company common during the ten consecutive trading day period immediately preceding the trading day that the Company receives the Notice of Conversion from the Firstfire. The Firstfire Note has limited piggy back registration rights and prepayment provisions attached. The Company paid original issuance cost of $30,000 in connection with this note payable which will be amortized over the term of the note. Since the convertible note was not repaid on October 27, 2017, the Company increased the principal amount of this note by $100,000 and recorded interest expense of $100,000 in 2017. On April 27, 2017, in connection with the Firstfire, the Company issued to Firstfire 250,000 shares of its common stock as additional consideration for the purchase of the Firstfire Note. The Company valued these shares at $320,000, or $1.28 per common share. In connection with the issuance of these shares, in 2017, the Company recorded interest expense of $320,000. This note contained representations, warranties, events of default, beneficial ownership limitations, and other provisions that are customary of similar instruments. The Company has accounted for this convertible promissory note as stock settled debt under ASC 480 and in 2017, the Company recorded a debt premium liability of $110,000 and a charge to interest expense of $110,000. On November 15, 2017, the Company entered into a Settlement Agreement and Stipulation (the “Settlement Agreement”) with Firstfire, pursuant to which the Company agreed to issue common stock to Firstfire in exchange for the settlement of $330,000 for the principal amount of the promissory note issued by the Company to Firstfire on Firstfire Note, plus $100,000 as set forth in section 3.1 in the Firstfire Note, plus default interest of 15% annually (the “Settlement Amount”) as provided for in the Firstfire Note. On November 28, 2017, the Circuit Court of Broward County, Florida (the “Court”), entered an order (the “Firstfire Order”) approving, among other things, the fairness of the terms and conditions of an exchange pursuant to Section 3(a)(10) of the Securities Act of 1933, as amended (the “Securities Act”), in accordance with a stipulation of settlement, pursuant to the Settlement Agreement, in the matter entitled Firstfire Global Opportunities Fund, LLC v. Eight Dragons Company (Case No. CACE-17-019524 (Div. 25) (the “Firstfire Action”). Firstfire commenced the Firstfire Action against the Company to recover the Settlement Amount (the “Firstfire Claim”) pursuant to the Firstfire Note. The Firstfire Note relate to certain funds lent to the Company by Firstfire. The Firstfire Order provides for the full and final settlement of the Firstfire Claim and the Firstfire Action. The Settlement Agreement became effective and binding upon the execution of the Firstfire Order by the Court on November 15, 2017. The Company’s obligations under the Firstfire Note were governed by and were replaced by the Company’s obligations under the Settlement Agreement. Pursuant to the terms of the Settlement Agreement approved by the Firstfire Order, on November 15, 2017, the Company agreed to issue to Firstfire shares (the “Firstfire Settlement Shares”) of the Company’s common stock upon conversion of the Settlement Amount by Firstfire. The Settlement Amount was convertible into common stock, at Firstfire’s option, at a conversion rate equal to 75% multiplied by the lowest traded price of the Company’s common stock during the ten consecutive trading day period immediately preceding the trading day that the Company receives a notice of conversion from Firstfire. The Settlement Agreement provides that the Firstfire Settlement Shares shall be issued in one or more tranches, as necessary, sufficient to satisfy the Firstfire Settlement Amount through the issuance of freely trading securities issued pursuant to Section 3(a)(10) of the Securities Act. Pursuant to the Settlement Agreement, Firstfire could deliver a request to the Company for shares of common stock to be issued to Firstfire (the “Firstfire Share Request”). The Settlement Agreement provides that in no event shall the number of shares of common stock issued to Firstfire or its designee in connection with the Settlement Agreement, when aggregated with all other shares of common stock then beneficially owned by Firstfire and its affiliates (as calculated pursuant to Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the rules and regulations thereunder), result in the beneficial ownership by Firstfire and its affiliates (as calculated pursuant to Section 13(d) of the Exchange Act and the rules and regulations thereunder) at any time of more than 4.99% of the outstanding common stock. As of December 31, 2017, no shares of the Company’s common have been issued pursuant to the Settlement Agreement other than 250,000 shares of common stock. On June 15, 2018, the Company and Firstfire entered into an Amendment to Settlement Agreement and Stipulation (the “Firstfire Amendment”) to amend the Settlement Agreement entered into on November 15, 2017. Pursuant to the terms of the Firstfire Amendment, the Company agreed to issue to Firstfire 1,000,000 shares (the “Settlement Shares”) of the Company’s common stock in full settlement of the claims set forth in the Settlement Agreement. The amount of Settlement Shares includes 250,000 shares of common stock previously issued to Firstfire in 2017 and an additional 750,000 shares to be issued by the Company upon approval of the Firstfire Amendment by the Court. The Company and Firstfire submitted the Firstfire Amendment to the Court for a hearing on the fairness of such terms and conditions, and the issuance exempt from registration of the Settlement Shares. The Firstfire Amendment became effective on July 9, 2018, when it was approved by the Court and the Company became obligated to issue the Settlement Shares, with such shares to be issued as freely trading securities pursuant to Section 3(a)(10) of the Securities Act of 1933, as amended. The number of Settlement Shares shall be subject to proportional adjustment in the event the Company issues or sells shares of the Company’s common stock for a consideration per share less than $0.64, or issue options, warrants or other securities convertible or exchange for shares of the Company’s common stock at a conversion or exercise price less than $0.64 per share, exclusive of certain issuances for compensation, existing agreements, acquisitions, issuances to contractors and vendors that are not for capital raising purposes. If any of these events should occur (other than the excluded events), the number of Settlement Shares shall be increased in proportion to the amount of the per share issuance price below $0.64. In addition, upon issuance of the Settlement Shares, Firstfire entered into an 18 month lock up agreement whereby it agreed not to sell any shares of the common stock it beneficially owns except as follows: (i) 25,000 shares during each consecutive month for a period of three consecutive months which commenced on the first full month after the date the Firstfire Amendment is approved by the Court (the “Order Date”), (ii) 50,000 shares per month for a period of three consecutive months commencing on the fourth month after the Order Date; (iii) 75,000 shares per month for a period of three consecutive months which commenced on the seventh month after the Order Date; and (iv) 100,000 shares each month for a period of three months which commenced on the tenth month after the Order Date. If, however, the dollar value of shares sold by Firstfire during the 18-month lock-up period exceeds $500,000, then the number of shares that may be sold during each month during the six consecutive months after such period shall be limited to 40,000. In addition, the Company agreed to reserve during the 18-month lock-up period 3,000,000 shares of its common stock subject to increase at the rate of three times the increase in the number of Settlement Shares if such amount is increased as a result of the anti-dilution protection discussed above. During the year ended December 31, 2018, 750,000 shares of the Company’s common were issued, in addition to the 250,000 shares of common stock issued in 2017, pursuant to the Settlement Agreement and Firstfire Amendment. The Firstfire Note had no outstanding principal and interest as of December 31, 2018. The shares of common stock comprising the Settlement Shares were issued in reliance upon the exemption from securities registration afforded by the provisions of Section 3(a)(10) of the Securities Act. At December 31, 2018 and 2017, accrued interest under this convertible note amounted to nil and $13,318, respectively, as included in accrued expenses on the accompanying consolidated balance sheets. At December 31, 2018 and 2017, convertible note payable consisted of the following: December 31, 2018 2017 Principal amount $ — $ 430,000 Add: debt premium liability — 110,000 Convertible notes payable, net $ — $ 540,000

SERIES B REDEEMABLE CONVERTIBLE

SERIES B REDEEMABLE CONVERTIBLE PREFERRED STOCK	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
NOTE 7 - SERIES B REDEEMABLE CONVERTIBLE PREFERRED STOCK	On July 26, 2018, the Company entered into a Stock Purchase Agreement with an accredited investor pursuant to which, at closing, the Company agreed to issue and sell to that investor up to 4,687,500 shares of its Series B Convertible Preferred Stock, $0.0001 par value (“Series B Preferred”) at a price of $0.64 per share for an aggregate of $3,000,000. An aggregate of 3,906,250 shares will be issued and sold in five monthly tranches of at least 781,250 shares ($500,000) each, which commenced onJuly 27, 2018, the initial closing date, for an aggregate of $2,500,000. After the earlier of the four-month period after the initial closing date or the sale of 3,906,250 shares and not later than six months after the date of the initial closing, the investor may, but shall not be obligated to, purchase from the Company in a single closing, up to an additional 781,250 shares, not previously sold and never to exceed the number of Series B Preferred, at a price of $0.64 per share. In connection with the Company’s obligations under the Stock Purchase Agreement, the Company and its parent, Rokk3r Labs, entered into a Security and Pledge Agreement. Pursuant to the terms of this agreement, Rokk3r Labs pledged as collateral security for the payment, performance and observance of all of the Company’s obligations under Security and Pledge Agreement, the Stock Purchase Agreement, the Investor Rights Agreement, and the Series B Preferred, securities owned by Rokk3r Labs with a value of approximately $16,000,000 (the “Collateral”). Rokk3r Labs may transfer any of its interests in the Collateral so long as the Company or Rokk3r Labs, at their option, (i) add the proceeds of such transfer to the Collateral or (ii) promptly pledge a first priority security interest in one or more securities identified in the Security and Pledge Agreement that have an aggregate value equal to or greater than the value of such proceeds, provided, however, (x) no replacement collateral shall be required unless the aggregate value of the then-remaining Collateral decreases below an amount that is equal to three (3) times the amount invested and (y) any such reserve equity interests used as replacement collateral shall be subject to the investor’s prior approval (not to be unreasonably withheld or delayed). Upon a default under the terms of the Security and Pledge Agreement, the Stock Purchase Agreement, the Investor Rights Agreement, or the Series B Preferred, the investor may, among other things, collect or take possession of the Collateral, proceed with the foreclosure of the security interest in the Collateral or sell, lease or dispose of the Collateral. The pledge of the Collateral shall (a) remain in full force and effect until (i) the Company has acquired 75% of Rokk3r Labs’ current ownership interests in the aggregate in the entities that make up the reserved equity interests and the Collateral, or (ii) 75% of the shares of Series B Preferred owned by the investor have been converted into the Company’s common stock or have been redeemed by the investor. In connection with the Company’s obligations under the Stock Purchase Agreement, we entered into an Investor Rights Agreement with the investor. Pursuant to the terms of this agreement, the Company agreed to, among other things, file a registration statement covering the investor’s resale of the common stock underlying the Series B Preferred (to the extent such shares are registrable under the Securities Act) within 60 days following demand by such investor, with such demand right permitted any time after 180 days after the effective date of a registration statement related to the Company’s first underwritten public offering of the Company’s common stock under the Securities Act (an “IPO”). In addition, the Company agreed to register such shares if the Company files a registration statement in connection with a public offering of its securities for cash. So long as the investor holds 75% of the Series B Preferred, the investor has similar demand registration rights if at any time we are eligible to use a Form S-3. All registration rights are subject to cut back to the extent the Company’s Chief Executive Officer makes a good faith determination that a registration statement would interfere with certain corporate events identified in such agreement. The investor has certain information, observer and inspection rights which permit such investor to receive certain financial statements on a periodic basis, budget and business plan information annually and such other information as the investor shall reasonably request. The investor is entitled to appoint two representatives to become members of the Company’s strategic advisory board for a period of no less than two years after the initial issuance of the Series B Preferred. The advisory board will be established by the Company’s Board to offer them and the Company strategic ideas and advice regarding potential businesses expansion and strategy of the Company as mandated from time-to-time by the Board, including development and location of Rokk3r Hubs, opportunity identification, pilot program identification and execution, deal origination, acquisitions and mergers and representation of the Company and its brand. The Company agreed to compensate the investor for the participation by its designees on the Company’s advisory board by issuing the investor 300,000 shares of the Company’s restricted common stock, with 50% of such shares vesting twelve months after the issuance date of the Series B Preferred and the 50% remaining balance vesting twenty-four months after the issuance date of the Series B Preferred, so long as at least one investor designee is a member of the advisory board at the time of vesting. In addition, the investor or its affiliates are entitled to, without additional charge, certain corporate educational services the Company provides to its clients. On July 26, 2018, the Company filed a certificate of designation, preferences and rights of Series B Preferred stock (the “Certificate of Designation”) with the Secretary of State of the State of Nevada to designate 4,687,500 shares of our previously authorized preferred stock as Series B Preferred stock. The Certificate of Designation and its filing was approved by the Company’s Board of Directors on July 26, 2018 without shareholder approval as provided for in the Company’s articles of incorporation and under Nevada law. The Certificate of Designation includes: · the original issue price of each share is $0.64 (the “Original Issue Price”), · the shares are entitled to one vote for each share of common stock that such shares of Series B Preferred are convertible into, · the shares do not pay dividends, · each share is convertible into shares of our common stock at a conversion rate of one share of common stock for each share of Series B Preferred, subject to adjustment as hereinafter set forth. In the event of a breach by us of the rights, preferences, powers, restrictions and limitations of the Series B Preferred, then the number of shares of our common stock issuable upon conversion will be increased to 1.1 shares of common stock for each share of Series B Preferred and the holder may exercise its redemption rights discussed below, · the conversion price of the Series B Preferred is subject to proportional adjustment in the event of stock splits, stock dividends and similar corporate events. In addition, the conversion price is subject to adjustment if we issue or sell shares of our common stock in one or more capital-raising transactions which results in gross proceeds to us of more than $500,000 at a purchase price per share of less than $0.64. If this event should occur, the number of shares of our common stock issuable upon conversion is increased on a pro-rata basis, and · the holder of the Series B Preferred has the right to elect to have all or any portion of the then outstanding shares of Series B Preferred redeemed by us at any time and from time to time on or after 18 months following the issuance of 3,906,250 shares or after any breach of the rights, preferences, powers, restrictions and limitations of the Series B Preferred for a price per share equal to 122.5% of the Original Issue Price, as adjusted. The information, observer, inspection and advisory board rights will terminate (i) immediately before the consummation of the IPO, (ii) when the Company first becomes subject to the periodic reporting requirements the Exchange Act or (iii) upon the closing of a deemed liquidation event (as defined in the Investor Rights Agreement), whichever event occurs first. The Series B Preferred is convertible into the Company’s common stock and/or redeemable at any time at the option of the holder or the Company in the events not controlled by the Company. The Company has classified the Series B Preferred mezzanine equity in the accompanying consolidated balance sheet in accordance with ASC 480 - " Distinguishing Liabilities from Equity During the year ended December 31, 2018, the Company sold 4,085,938 shares of the Series B Preferred for net proceeds of $2,615,000 or $0.64 per preferred. As of December 31, 2018, 4,085,938 shares of Series B Preferred were issued and outstanding. The Company also recorded a redemption premium of $104,419 in connection with the issuance of the Series B Preferred during the year ended December 31, 2018.

SHAREHOLDERS' EQUITY

SHAREHOLDERS' EQUITY	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
NOTE 8 - SHAREHOLDERS' EQUITY	Shares Authorized On March 8, 2018, the Company filed Amended and Restated Articles of Incorporation (the “Amended and Restated Articles”) with the Nevada Secretary of State to increase our authorized capital from 150,000,000 shares to 550,000,000 shares of which 500,000,000 are common stock (”common stock”), par value $0.0001 per share and 50,000,000 are preferred stock (“preferred stock”), par value $0.0001 per share of which 1,000,000 shares were designated as Series A Preferred stock (“Series A Preferred”). On July 26, 2018, we filed the Certificate of Designation to designate 4,687,500 shares of our previously authorized preferred stock as Series B Convertible Preferred stock (“Series B Preferred”). Series A Preferred: Non-Convertible Preferred Stock Effective on April 12, 2017, in conjunction with the filing of the amendment to the Company's Articles of Incorporation with the Nevada Secretary of State, specifically a Certificate of Designation, the Company amended its Articles of Incorporation to designate 1,000,000 shares of its authorized preferred stock as Series A Preferred with specific rights and preferences including the provision that each share of the Series A Preferred shall have one thousand votes on all matters presented to be voted by the holders of common stock. The Series A Preferred is not convertible to common stock. On April 12, 2017, the Company issued 1,000,000 shares of Series A Preferred to Una Taylor, our former Chief Executive Officer and controlling shareholder in consideration for services rendered. In connection with the issuance of the Series A Preferred, the Company recorded stock-based compensation expense of $37,500. On December 26, 2017, Ms. Taylor cancelled the 1,000,000 shares of Series A Preferred Stock previously issued to her as provided for in the Rescission and Mutual Release Agreement entered into between the Company and Ms. Taylor dated December 26, 2017 (the “Taylor Rescission Agreement”) (see Note 1). Upon cancellation in December 2017, the Company reversed the previously recorded stock-based compensation expense of $37,500. As of December 31, 2018, there were no outstanding shares of Series A Preferred stock. Series B Preferred: Redeemable Convertible Preferred Stock On July 26, 2018, the Company filed the Certificate of Designation with the Nevada Secretary of State to designate 4,687,500 shares of our previously authorized preferred stock as Series B Preferred. The Certificate of Designation and its filing was approved by the Company’s Board of Directors on July 26, 2018 without shareholder approval as provided for in the Company’s articles of incorporation and under Nevada law. The Series B Preferred is convertible into the Company’s common stock and/or redeemable at any time at the option of the holder or the Company in the events not controlled by the Company. The Company has classified the Series B Preferred as mezzanine equity in the accompanying consolidated balance sheet in accordance with ASC 480 - Distinguishing Liabilities from Equity Common Stock On April 28, 2017, as consideration for services, the Company issued 9,710,295 shares of its common stock to the Company’s former Chief Executive Officer, Una Taylor. These shares were valued at $12,429,178, or $1.28 per common share. Accordingly, the Company recorded stock-based compensation of $12,429,178. The Company and Ms. Taylor rescinded certain transactions between the Company and Ms. Taylor, and in connection therewith Ms. Taylor returned to the Company the 9,710,295 shares of common stock for no additional consideration. In connection therewith, the Company and Ms. Taylor entered into the Taylor Rescission Agreement. Additionally, the Company and Eight Dragons Acquisition, LLC (“Eight Dragons LLC”), an affiliate of Ms. Taylor, rescinded certain transactions between the Company and Eight Dragons LLC, and in connection therewith Eight Dragons LLC returned to the Company 290,500 shares of common stock, for no additional consideration. On April 28, 2017, as consideration for services rendered and to be rendered, the Company issued an aggregate of 16,518,108 shares of the Company’s common stock to individuals and entities. These shares were valued at $21,143,178, or $1.28 per common share. Accordingly, the Company recorded stock-based consulting expense of $21,143,178. Subsequent to September 30, 2017, pursuant to rescission agreements and due to lack of performance, the Company cancelled 6,150,000 shares of these common shares. In connection with the cancellation of these shares, the Company reduced stock-based consulting fees by $6,592,000. Additionally, on November 21, 2017, the Company and Trident capX Corporation (“Trident”) entered into a Stock Redemption and Release Agreement (the “Trident Redemption Agreement”), pursuant to which the Company redeemed 9,710,295 of these shares of common stock from an entity for a total consideration of $1.00, and wherein the parties each released each other from any claims one may have had against the other. In April 2017, upon the assumption of the DreamFu Convertible Debentures (see Note 1), debentures aggregating $1,517,800 were converted into 1,355,783 shares of the Company’s common stock. Effective as of June 30, 2017, the Company entered into an amendment to the DreamFu Convertible Debentures with the Purchasers whereby the Company agreed to issue an aggregate of 1,185,783 shares of its unregistered common stock in satisfaction of any additional conversion rights of each of the respective Purchasers and in full satisfaction of the obligations of the Company and DreamFu under the DreamFu Convertible Debenture. On April 27, 2017, in connection with the Firstfire Note, the Company issued Firstfire 250,000 shares of its common stock as additional consideration for the purchase of the Firstfire Note. The Company valued these shares at $320,000, or $1.28 per common share. In connection with the issuance of these shares, the Company recorded interest expense of $320,000. On April 30, 2017, the Company purchased a non-controlling interest in Rokk3r Labs, specifically an aggregate of 18.72% of the Member Interests of Rokk3r Labs for a purchase price of $1,000,000 (provided at the direction of an entity controlled by Una Taylor for the benefit of the Company) and the issuance of 9,677,208 shares of Company common stock valued at $12,386,826, or $1.28 per common share (the “Rokk3r Labs Equity Purchase Agreement”). In June 2017, the Company issued 80,000 shares of its common stock for an investment in Park Road Solutions. The Company valued these shares at $102,400, or $1.28 per common share. On September 30, 2017, based on an impairment analysis, the Company wrote off its investment and recorded an impairment loss of $102,400. On June 30, 2017, as consideration for 6,100,000 shares of PRTT, the Company issued 3,000,000 shares of its common stock valued at $3,840,000, or $1.28 per common share. On November 19, 2017, the Company and PRTT entered into PRTT Rescission Agreement, pursuant to which the parties rescinded certain transactions between them, and in connection therewith PRTT returned to the Company 3,000,000 shares of common stock, and the Company returned to PRTT 6,100,000 shares of common stock of PRTT that the Company had acquired in the transactions, and the parties each released each other from any claims one may have had against the other. In connection with the PRTT Rescission Agreement, the Company reversed its investment in PRTT of $3,840,000 to equity and cancelled the 3,000,000 shares of its previously issued common stock. On December 4, 2017, the Company and Rokk3r Fuel and Rokk3r Fund Fuel 2 GP, LLC, the General Partner of Rokk3r Fuel (“GP”) entered into a Stock Issuance and Release Agreement (the “Stock Issuance Agreement”), pursuant to which Rokk3r Fuel and GP released the Company from certain claims that Rokk3r Fuel and GP may have had against the Company due to a previous subscription that the Company had made for an investment in Rokk3r Fuel, but which the Company had not completed, in return for the issuance to Rokk3r Fuel of 7,500,000 shares of common stock, which issuance was completed on December 4, 2017. The Stock Issuance Agreement also provides that the Company similarly releases its claims against Rokk3r Fuel and GP, and recites that it is the intention of Rokk3r Fuel to contribute approximately $5 million of capital or assets to the Company in the upcoming three years. However, there is no binding obligation on Rokk3r Fuel to make any such contribution and there can be no assurance that it will occur, or of the terms, conditions or timing thereof. Pursuant to an Asset and Intellectual Property Contribution and Assignment Agreement entered into between the Company and Rokk3r Labs dated December 26, 2017 (the “Contribution and Assignment Agreement”), Rokk3r Labs contributed to the capital of the Company certain intellectual property assets of Rokk3r Labs in exchange for the issuance to Rokk3r Labs of 74,050,000 shares of unregistered common stock. The Contribution and Assignment Agreement was entered into as one of the conditions to the Restructuring Agreement. The Company determined that the contributed intellectual properties had no value. Pursuant to the Restructuring Agreement, the Company agreed that, following the Closing and until January 31, 2019 (the “Deadline”), Ms. Taylor will have the right to elect to have the Company issue to Ms. Taylor either (i) an option to acquire 4,000,000 shares of common stock, which option will be at a strike price of $0.0001 per share of common stock, and which option will be exercisable for a period of 16 months from the issuance thereof or (ii) 4,000,000 shares of common stock. The number of options or shares of common stock to be issued is subject to adjustment and possible return to the Company as set forth in the Restructuring Agreement. In the event that Ms. Taylor has not made such election on or prior to the Deadline, the rights of Ms. Taylor to receive the options or shares will be automatically forfeited. The Company has also agreed to grant Ms. Taylor customary registration rights with respect to the shares of common stock as may be obtained by Ms. Taylor as described above. Ms. Taylor’s rights to receive the shares or options, and Ms. Taylor’s registration rights, may be assigned by Ms. Taylor to (i) any entity which is 100% owned and controlled by Ms. Taylor; or (ii) any entity that is owned and controlled 80% by Taylor and 20% by Titan Funding, LLC, an affiliate of Ms. Taylor, subject, in the case of this sub clause (ii) only, to the reasonable approval of the Company. The Company has reserved an aggregate of 2,650,000 shares of its common stock that were previously issued, but never delivered to the prospective shareholders, in anticipation of completing certain transactions that never closed (the “Cancellation Shares”). See Note 11 as to 1,150,000 shares held in reserve as a result of a claim by Jordan Fishman and as to 1,250,000 shares held in reserve as a result of a claim by Sean Young. 250,000 shares are in the process of being cancelled pending completion of additional documentation by the Company to substantiate their cancellation. The cancellation has not been completed as of December 31, 2018. On November 2,2018, pursuant to the Retainer Agreement with Mr. Ismail, the Company granted 1,000,000 shares of common stock, for 4 years of service, with 25% of such common stock shares vesting at the end of each calendar year, with the first vesting date on December 31, 2019, as long as Mr. Ismail remains a member of the Board and continues to fulfill his duties and provide the services during the corresponding vesting period. Such 1,000,000 shares of the Company’s common stock are to be issued and thus has been reflected as common stock issuable as of December 31, 2018 (see Note 12). During the year ended December 31, 2018, pursuant to subscription agreements, the Company sold 5,836,532 shares of its common stock for proceeds of $3,735,380, or $0.64 per common share. During the year ended December 31, 2018, pursuant to a consulting agreement, the Company issued 12,286 shares of its common stock with grant date fair value of $25,800 in connection with services rendered. During the year ended December 31, 2018, the Company’s issued 750,000 shares of common stockwere issued, pursuant to the Settlement Agreement and Firstfire Amendment (see Note 6). Equity Compensation Plans 2017 Omnibus Equity Compensation Plan On April 12, 2017, the Board adopted a Financial Code of Ethics and adopted the 2017 Omnibus Equity Compensation Plan and approved to reserve 5,000,000 shares of common stock for future issuance under the 2017 Omnibus Equity Compensation Plan. As of December 31, 2018 and 2017, no equity instruments have been issued under the 2017 Omnibus Equity Compensation Plan. 2018 Equity Incentive Plan On March 7, 2018, the Board approved, and on March 28, 2018, our shareholder approved, by written consent, the 2018 Equity Incentive Plan. The 2018 Equity Incentive Plan is intended to make available incentives that will assist us to attract, retain and motivate employees, including officers, consultants and directors. We may provide these incentives through the grant of stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares and units and other cash-based or stock-based awards. A total of 15,000,000 shares of the Company’s common stock werereserved under the 2018 Equity Incentive Plan. The shares authorized under the 2018 Equity Incentive Plan automatically increase on January 1, 2019 and each subsequent anniversary through 2028, by an amount equal to the smaller of (a) 3% of the number of shares of common stock issued and outstanding on the immediately preceding December 31, or (b) an amount determined by the Board. As of December 31, 2018, no equity instruments have been issued under the plan. Approved Grant of Common Stock as Incentive for Employees and Contractors On November 16, 2018, our Board approved the grant of stock-based awards of its common stock by Rokk3r Ops Inc. as signing bonuses to attract innovative, creative and experience individuals to join by Rokk3r Ops Inc. in the aggregate amount of not more than $352,000, represented by 550,000 shares, to be vested as per an agreed upon vesting schedule (the “Vesting Date”). At Vesting Date, the shares shall be issued; notwithstanding the foregoing, the Board may at any time accelerate the Vesting Date. As of the date of this report, although the share issuances were approved, no shares pursuant to the foregoing have been issued.

CONCENTRATIONS

CONCENTRATIONS	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
NOTE 9 - CONCENTRATIONS	Concentrations of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash deposits. The Company maintains its cash in financial institutions in the United States for which balances are insured up to Federal Deposit Insurance Corporation limits of $250,000 per account. At December 31, 2018 and 2017, the Company had a cash balance of $2,297,902 and $0, respectively. The Company has not experienced any losses in such accounts through December 31, 2018. Concentrations of Revenue During the year ended December 31, 2018, the Company had revenue $2,301,939 of which 19% and 12% were from two of the Company’s customers.During the year ended December 31, 2017, the Company did not have any revenue. A reduction in revenue from or loss of such customers would have a material adverse effect on the Company’s consolidated results of operations and financial condition. Concentrations of Accounts Receivables During the year ended December 31, 2018, the Company had gross account receivable of $549,165 of which 42% was from a Company’s customer. During the year ended December 31, 2017, the Company did not have any account receivable.

RELATED-PARTY TRANSACTIONS

RELATED-PARTY TRANSACTIONS	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
NOTE 10 - RELATED-PARTY TRANSACTIONS	On March 13, 2017, DreamFu Angels, LLC (d/b/a DreamFu Ventures, LLC) (“DreamFu”), a related party controlled by Una Taylor, the Company’s former Chief Executive Officer completed the sale of aggregate principal amount Convertible Debentures of $1,517,800 (the “DreamFu Convertible Debentures”) in a private placement financing transaction with certain private investors (the “Purchasers”). The Company assumed the DreamFu Convertible Debentures in lieu of completing a merger with DreamFu in return for a related party making payments for the benefit of, and at the direction of, the Company in the amount of $1,396,371. Upon the assumption of the DreamFu Convertible Debentures, they were converted into 1,355,783 shares of the Company’s unregistered common stock. Effective as of June 30, 2017, the Company entered into an amendment to the DreamFu Convertible Debentures with the Purchasers whereby the Company agreed to issue an aggregate of 1,185,783 shares of its unregistered common stock in satisfaction of any additional conversion rights of each of the respective Purchasers and in full satisfaction of the obligations of the Company and DreamFu under the DreamFu Convertible Debenture. Ms. Taylor retains an obligation to wire the remaining $121,429 to the Company and thus holds the funds for the benefit of the Company. As of December 31, 2017, the Company had not received these funds and cannot determine if such funds will be used for the benefit of the Company. Accordingly, the Company reclassified amounts due to compensation expense. On April 30, 2017, the Company and Rokk3r Labs entered into the Rokk3r Labs Equity Purchase Agreement (see Note 8). On December 4, 2017, the Company and Rokk3r Fuel and Rokk3r Fund Fuel 2 GP, LLC, the General Partner of Rokk3r Fuel entered into a Stock Issuance and Release Agreement (see Note 8). On December 26, 2017, the Company entered into a restructuring agreement (the “Restructuring Agreement”) and the Release Agreements with Una Taylor, the former Chief Executive Officer and substantial stockholder of the Company, and Rokk3r Labs (see Note 1 and 8). On December 26, 2017, the Company and Rokk3r Labs entered into an Asset and Intellectual Property Contribution and Assignment Agreement (see Note 1 and 8). Due to Parent Company During the year ended December 31, 2018, the Company’s controlling shareholder, Rokk3r Labs, advanced the Company $154,700 and repaid $229,838 for working capital purposes. The advances are non-interest bearing and are receivable or payable on demand. At December 31, 2018 and 2017, the Company had $75,138 receivable and $16,492 payable balance from/to Rokk3r Labs, respectively. Collaboration Agreement – Parent Company On April 9, 2018, the Company entered into a collaboration agreement with Rokk3r Labs, the Company’s controlling shareholder (the “Collaboration Agreement”). Under the terms of the Collaboration Agreement, initially, Rokk3r Labs will provide the following services to the Company on a non-exclusive, as-needed basis: delivery support of products such as consultancy services and software development services; sales support and promotion for company building and consulting services; and promotional activity, events, branding, and marketing. Once the Company is ready to undertake some or all of these activities, Rokk3r Labs will narrow down the services it performs on behalf of the Company. Each party, based on its cost structure, will define the fees for the services to be provided and will invoice the other party for the services actually rendered on a monthly basis. The term of the Collaboration Agreement commenced on January 1, 2018 and has a term of two years. However, the parties may, by mutual agreement, terminate the Collaboration Agreement or renew it for an additional one-year period. In connection with the Collaboration Agreement, during the year ended December 31, 2018, the Company recorded $2,701,250 of consulting fees – parent company and $175,000 of prepaid expense – related party in connection with the Collaboration Agreement. Trademark License Agreement – Parent Company On November 15, 2018, the Company entered into a Trademark License Agreement with Rokk3r Labs. Pursuant to which, Rokk3r Labs granted the Company and its subsidiaries, a limited, worldwide, non-exclusive, non-transferable, license to use the trademark ROKK3R in word form and in all style and design variations used to date by Rokk3r Labs or its authorized licensees, until November 12, 2019. The agreement may automatically renew for successive one-year terms unless terminated by either party. If a party elects not to renew the agreement, that party shall provide a notice of that intention to the other party at least 30 days prior to the renewal date. Pursuant to the agreement, the Company shall pay an annual fee of $120,000, payableon the anniversary of the effective date of the agreement. The Company recorded $15,000 in accrued expense – related party in the consolidated balance sheet as of December 31, 2018, in connection with the Trademark License Agreement. Consulting Services Agreement On June 21, 2018, a Consulting Services Agreement was signed between ExO Foundation, Inc. which is owned and controlled by Salim Ismail, a member of the Board of Directors of the Company, and Rokk3r Ops for the pre-purchase of $250,000 in future services such as consultants, advisors and speakers to be rendered by ExO Foundation, Inc, or through ExO Lever Network. The services are represented in vouchers to be used in the next two years (in the event of conversion into another instrument without expiration within such two-year period) or within Ten (10) years if the vouchers are not converted into another instrument. The vouchers are transferable and assignable. The $250,000 payment was recorded as prepaid expense – related party in the consolidated balance sheet as of December 31, 2018. Stock Purchase Agreement On November 2, 2018, the Company entered into a stock purchase agreement (the “SPA”) with ExO Foundation Inc., a Delaware public benefit corporation (“EXO”) which is owned and controlled by Salim Ismail, a member of the Board of Directors of the Company. Pursuant to the SPA, the Company agreed to issue and sell to EXO, 5,000,000 shares of the Company’s common stock in exchange for EXO and the Company entering into a Simple Agreement for Future Equity with Token Allocation (the “Safe-T Agreement”). Pursuant to the SPA, EXO agreed that during the 24 month period after the date of execution of the Safe-T Agreement, EXO will not directly or indirectly, sell or engage in any transaction that will result in a change in the beneficial or record ownership of 50% of the common stock issued to EXO pursuant to the SPA. Further, pursuant to the SPA, EXO agreed not to transfer any of the common stock issued to EXO pursuant to the SPA during the 24 month period after the date of execution of the Safe-T Agreement without first giving the Company written notice of such proposed transfer and allowing the Company the option to purchase the common stock at issue on the same terms as contemplated by such proposed transfer. The SPA includes customary representations, warranties and covenants by the Company and EXO and customary closing conditions. As of December 31, 2018, no shares of common stock had been issued in connection with the SPA. Safe-T Agreement On November 2, 2018, the Company and EXO which is owned and controlled by Salim Ismail, a member of the Board of Directors of the Company, entered into the Safe-T Agreement. Pursuant to the Safe-T Agreement, at EXO’s election, the Company has the right to purchase a number of units of CivX Tokens (each a “Token” and together the “Tokens”) to be used in a software network platform or application built by EXO and its affiliates, equal to the Purchase Amount, as such term is defined in the Safe-T Agreement and discussed below, divided by the Price Per Token, as such term is defined in the Safe-T Agreement and discussed below. Further, pursuant to the Safe-T Agreement, EXO agreed that if it conducts an Equity Financing as such term is defined in the Safe-T Agreement, prior to the termination of the Safe-T Agreement, EXO will issue to the Company a number of shares of EXO’s preferred stock equal to the Purchase Amount, as such term is defined in the Safe-T Agreement, divided by the price per share of the preferred stock sold by EXO in the Equity Financing. The Safe-T Agreement defines the term “Equity Financing” as a bona fide transaction or series of transactions with the principal purpose of raising capital, pursuant to which EXO issues and sells its preferred stock at a fixed pre-money valuation with aggregate proceeds of at least $5,000,000 (excluding any Simple Agreements for the Future Equity with Token Allocations, Simple Agreements for the Future Equity, or other convertible securities converting pursuant to the Equity Financing). The Safe-T Agreement defines the term “Purchase Amount” as follows: (a) the value of 5,000,000 shares of the Company’s common stock (the “Purchaser Shares”) to be either (i) the publicly traded price of the Purchaser Shares at the time of the calculation, with the express requirement that if the Purchaser Shares are then trading at over $3.00 then that will be the maximum value of the Purchaser Shares and if the Purchaser Shares are then trading under $0.64 then that will be the minimum value of the Purchaser Shares or (ii) if the Purchaser Shares are not publicly traded at such time, the value of such shares shall be the fair market value, up to but not exceeding $3.00 (referred to as the “Adjusted Value”); (b) with a discount rate of 85% to be applied to the Adjusted Value to determine the final value of the “Purchase Amount.” The Safe-T Agreement defines the term “Price Per Token” as the fair market value of an individual Token at the time of the Token Sale, as such term is defined in the Safe-T Agreement; provided, however, that if there is no public market for the Tokens at the time of the Token Sale, the price per Token shall be determined by an independent third party valuation firm or expert, as mutually agreed between Company and EXO. The Safe-T Agreement defines the term “Token Sale” as a bona fide transaction or series of transactions in which EXO elects to sell all of the Tokens to the Company pursuant to the Safe-T Agreement. The Safe-T Agreement will terminate upon either the earlier of the following (i) the issuance of all of the Tokens by EXO to the Company pursuant to the Safe-T Agreement (ii) the issuance of all of the shares in the Equity Financing pursuant to the Safe-T Agreement (iii) upon payment by EXO to the Company in the event of an occurrence of a Dissolution Event or Liquidity Event, as such terms are defined in the Safe-T Agreement or (iv) 24 months after the date of execution of the Safe-T Agreement. The Safe-T Agreement defines the term “Liquidity Event” as a change of control of EXO or an initial public offering by EXO. The Safe-T Agreement defines the term “Dissolution Event” as (i) a voluntary termination of operations of EXO; (ii) a general assignment for the benefit of EXO’s creditors; or (iii) any other liquidation, dissolution or winding up of EXO (excluding a Liquidity Event), whether voluntary or involuntary. Upon the occurrence of a Liquidity Event or a Dissolution Event, EXO will have to pay the Company a cash amount equal to the Purchase Amount. Upon the occurrence of the termination of the Safe-T Agreement pursuant to the 24 month expiration EXO will have to deliver to the Company either the Purchaser Shares, cash in an amount equal to the Purchase Amount or an amount of equity in EXO equal to the Purchase Amount. Pursuant to the Safe-T Agreement, the Company agreed that if Tokens are issued to the Company pursuant to the Safe-T Agreement, that the Company would not transfer 50% of such Tokens for a period of 12 months from the issuance of the Tokens. The Safe-T Agreement includes customary representations, warranties and covenants by the Company and EXO. As of December 31, 2018, the Company had not received any proceeds or issued shares in connection with the Safe-T Agreement.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
NOTE 11 - COMMITMENTS AND CONTINGENCIES	Rokk3r Fuel On August 18, 2017, the Company and Titan Funding, LLC (“Titan Funding”), an affiliate of Ms. Taylor, entered into an Assignment of Limited Partnership Interest (the “Rokk3r Labs Fuel Assignment”) related to the Company’s obligation to acquire limited partnership interests in Rokk3r Fuel Fund 2, LP (“Rokk3r Fuel”). During August 2017, pursuant to the Rokk3r Fuel Assignment the Company received a total of $268,750 from Titan Funding and paid $200,000 to Rokk3r Fuel during August 2017 leaving a balance due of $68,750. On December 4, 2017, the Company issued 7,500,000 shares of its unregistered common stock in exchange for a release from Rokk3r Fuel for any past or future obligations of the Company to provide funding and a confirmation of Rokk3r Fuel’s intention to contribute approximately $5,000,000 of capital or assets into the operations of the Company over the three years following the date of this agreement. Park Road Solutions, LLC and Jordan Fishman On June 1, 2017, the Company, Eight Dragons Acquisition I, Inc., Park Road Solutions, Inc. (“Park Road”) and Jordan Fishman ostensibly signed an Agreement and Plan of Merger and Reorganization (the “Park Road Merger Agreement”) to acquire all of the issued and outstanding common shares of Park Road from Mr. Fishman in exchange for 80,000 shares of the Company’s common stock (the “Park Road Acquisition”). The Company rescinded the Park Road Merger Agreement, ab initio, due to, among other things, its legal insufficiency, a lack of consideration on the part of Mr. Fishman and Park Road and their failure to fulfill their obligations as provided for in the Merger Agreement. On May 8, 2017, the Company’s transfer agent issued 1,150,000 shares of its common stock in the name of Jordan Fishman in anticipation of acquiring an entity owned or controlled by Mr. Fishman. The plan to acquire the entity was abandoned prior to closing and the 1,150,000 shares of common stock were never delivered to Mr. Fishman and were cancelled. Mr. Fishman has disputed the Company’s right to rescind the Park Road Merger Agreement, demanded that the Company deliver the 1,150,000 shares of the Company’s common stock without providing any legal basis for such demand and further demanded reimbursement of $36,626 for services and expenses ostensibly advanced for the benefit of Park Road. The Company believes its right to rescind the Park Road Acquisition, has no legal obligation to deliver the 1,150,000 shares common stock to Mr. Fishman and disputes his other demands. If Mr. Fishman pursues legal action against the Company, the Company intends to vigorously defend its rights against Mr. Fishman. Pending the outcome of the dispute with Mr. Fishman, the Company has reserved 1,150,000 shares of its common stock for possible issuance in the event of a determination by a court of law or subsequent agreement between the Company and Mr. Fishman. Sean Young Demand On May 8, 2017, the Company’s transfer agent issued 1,250,000 shares of its common stock in the name of Sean Young in anticipation of acquiring an entity owned or controlled by Mr. Young. The plan to acquire the entity was abandoned prior to closing and the 1,250,000 shares were never delivered to Mr. Young and were cancelled. On March 26, 2018, Mr. Young demanded that the Company deliver the 1,250,000 shares of common stock without providing any legal or factual basis for such demand and additionally demanded payment of $29,000 for services and expenses ostensibly advanced for the benefit of Park Road. The Company believes it has no legal obligation to deliver the 1,250,000 shares of common stock to Mr. Young and disputes his demand for payment. If Mr. Young pursues legal action against the Company, the Company intends to vigorously defend its rights against Mr. Young. Pending the outcome of the dispute with Mr. Young, the Company has reserved 1,250,000 shares of its common stock for possible issuance in the event of a determination by a court of law or subsequent agreement between the Company and Mr. Young. Press Media Group, Inc. On March 9, 2018, the Company and Rokk3r Labs LLC (collectively, the “Plaintiffs”) filed a complaint against Press Media Group Inc., a Delaware corporation (“Press Media”), and Alberto Marzan, the founder and Chief Executive Officer of Press Media (collectively, the “Defendants”) in the Circuit Court of the Eleventh Judicial Circuit in and for Miami-Dade County, Florida (Case No. 2018-007600-CA-01 CA08) (the “Rokk3r Complaint”). The complaint seeks relief for anticipatory breach of contract and declaratory judgement and alleges that the Defendants breached a joint venture agreement (the “JV Agreement”) pursuant to which the Company and the Defendants agreed to use their respective know-how and resources to acquire Afrostream Inc., a third-party company by failing to repay a $35,000 loan. The complaint seeks relief for fraudulent concealment and alleges that while the Company fulfilled its obligations under the JV Agreement by using their best efforts to procure funding for the acquisition and loaning $35,000 to Press Media for such purpose, the Defendants thwarted the deal by failing to provide the necessary due diligence and failing to disclose to the Company and potential investors Mr. Marzan’s criminal history as a convicted felon and accusations against him for insurance fraud. The complaint ultimately seeks relief in the form of: (i) damages incurred as a result of Mr. Marzan’s fraudulent concealment and failure to repay loans of at least $35,000; (ii) an award of attorneys’ fees, costs and disbursements; (iii) a declaration that Plaintiffs are not liable to Press Media in tort or contract; and (iv) an award of further relief as deemed just and proper. On March 16, 2018, the Defendants filed a separate complaint against the Company and Rokk3r Labs in the Circuit Court of the Eleventh Judicial Circuit in and for Miami-Dade County, Florida. The complaint brought by the Defendants alleges breach of contract, breach of fiduciary duty, fraud in the inducement, existence of a quasi-contract, and aiding and abetting all of which stem from or relate to the JV Agreement. The Defendants have since dismissed their lawsuit, but have filed counterclaims to the Rokk3r Complaint that are identical to those set forth in the dismissed complaint. On October 18, 2018, the court struck the Defendants’ pleadings and entered default against them for repeated failures to comply with the court’s orders. Following this entry of default, on December 4, 2018, the court entered Final Default Judgment against the Defendants and in favor of the Company and Rokk3r Labs. In the Final Default Judgment, the Company and Rokk3r Labs were awarded $35,000 with 6.09% interest per annum, against Press Media. The Final Default Judgment was not appealed. The Final Default Judgment of $35,000 and accrued interest receivable were accounted for as gain contingency in accordance with ASC 450-30 Gain Contingencies and will be recognized when payment is received. Further, management assessed that the probability of collection is remote since Press Media is currently in default on other financial obligations through default judgments not related to the Company. Stock Purchase Agreement On November 2, 2018, the Company entered into a SPA with EXO which is owned and controlled by Salim Ismail, a member of the Board of Directors of the Company. Pursuant to the SPA, the Company agreed to issue and sell to EXO, 5,000,000 shares of the Company’s common stock in exchange for EXO and the Company entering into the Safe-T Agreement as discussed above in Note 10. Safe-T Agreement On November 2, 2018, the Company and EXO which is owned and controlled by Salim Ismail, a member of the Board of Directors of the Company, entered into the Safe-T Agreement. Pursuant to the Safe-T Agreement, at EXO’s election, the Company has the right to purchase a number of units of Tokens to be used in a software network platform or application built by EXO and its affiliates, equal to the Purchase Amount, as such term is defined in the Safe-T Agreement, divided by the Price Per Token, as such term is defined in the Safe-T Agreement and discussed above in Note 10. Other than as set forth above, we are not presently a party to any material litigation that may have a material adverse effect on our consolidated financial position, results of operations or cash flows.

EMPLOYMENT CONTRACTS AND STOCK

EMPLOYMENT CONTRACTS AND STOCK COMPENSATION	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
NOTE 12 – EMPLOYMENT CONTRACTS AND STOCK COMPENSATION	On November 2, 2018, the Board of the Company increased the number of directors on the Board from three to five in accordance with the Company’s Articles of Incorporation, as amended and Bylaws. On the same date, the Company appointed Salim Ismail to fill one of the spots created by the increase to the Board and appointed Mr. Ismail to serve as member of the Board of the Company effective November 2, 2018, and to serve in such position for the remainder of the term of the other members of the Board or until replaced or upon his resignation. In connection with the appointment of Mr. Ismail to the Board, the Company entered into a Board of Directors Retainer Agreement (the “Retainer Agreement”) with Mr. Ismail, pursuant to which the Company agreed to pay Mr. Ismail the following compensation for his services: 1,000,000 shares of the Company’s $0.0001 par value per share common stock, for 4 years of service, with 25% of such common stock shares vesting at the end of each calendar year, with the first vesting date on December 31, 2019, as long as Mr. Ismail remains a member of the Board and continues to fulfill his duties and provide the services during the corresponding vesting period. Notwithstanding the foregoing, if Mr. Ismail’s appointment is terminated prior to 4 years of service, at any time after the first vesting period, Mr. Ismail will continue to earn the common stock shares in the agreed upon quantity; however, the vesting period of the remaining common stock shares will then move to the end of the fourth calendar year, which would be December 31, 2022. However, the Board, in its discretion, may at any time accelerate the vesting period for the common stock shares under the Retainer Agreement. Such 1,000,000 shares of the Company’s common stock are to be issued and thus has been reflected as common stock issuable as of December 31, 2018. The term of the Retainer Agreement is from the date of execution until Mr. Ismail either resigns or is terminated from such position in accordance with the Company’s Articles of Incorporation, as amended and Bylaws. Pursuant to the Retainer Agreement, the Company shall not pay Mr. Ismail any extra fees for each regularly scheduled meeting of the Board that he attends in person, nor for attending meetings telephonically. Additionally, pursuant to the Retainer Agreement, if Mr. Ismail is designated to participate in a committee of the Board as either a chairperson or non-chairperson member, he will be entitled to receive compensation in addition to the compensation previously agreed, in amounts to be later approved by the Board at the moment of such committee appointment.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
NOTE 13 – INCOME TAXES	The Company maintains deferred tax assets and liabilities that reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The deferred tax assets at December 31, 2018 and 2017 consist of net operating loss carryforwards. The net deferred tax asset has been fully off-set by a valuation allowance because of the uncertainty of the attainment of future taxable income. On December 22, 2017, the United States signed into law the Tax Cuts and Jobs Act (the “Act”), a tax reform bill which, among other items, reduces the current federal income tax rate to 21% from 34%. The rate reduction is effective January 1, 2018, and is permanent. The Act has caused the Company’s deferred income taxes to be revalued. As changes in tax laws or rates are enacted, deferred tax assets and liabilities are adjusted through income tax expense. Pursuant to the guidance within SEC Staff Accounting Bulletin No. 118 (“SAB 118”), as of December 31, 2017, the Company recognized the provisional effects of the enactment of the Act for which measurement could be reasonably estimated. Since the Company has provided a full valuation allowance against its deferred tax assets, the revaluation of the deferred tax assets did not have a material impact on any period presented. The ultimate impact of the Act may differ from these estimates due to the Company’s continued analysis or further regulatory guidance that may be issued as a result of the Act. The items accounting for the difference between income taxes at the effective statutory rate and the provision for income taxes for the years ended December 31, 2018 and 2017 were as follows: Years Ended December 31, 2018 2017 Income tax benefit at U.S. statutory rate of 21% in 2018 and 34% in 2017 $ (716,058 ) $ (12,885,417 ) Income tax benefit – state (187,539 ) (1,894,914 ) Non-deductible expenses 69,098 14,389,886 Effect of change in effective rate — 130,148 Change in valuation allowance 834,499 260,297 Total provision for income tax $ — $ — The Company’s approximate net deferred tax asset as of December 31, 2018 and 2017 was as follows: Deferred Tax Asset: Years Ended December 31, 2018 2017 Net operating loss carryforward $ 1,350,223 $ 507,297 Total deferred tax asset 1,350,223 507,297 Less: Valuation allowance (1,350,223 ) (507,297 ) Net deferred tax asset $ — $ — The net operating loss carryforward was approximately $5,095,180 at December 31, 2018. The Company provided a valuation allowance equal to the net deferred income tax asset as of December 31, 2018 because it was not known whether future taxable income will be sufficient to utilize the loss carryforward. The potential tax benefit arising from the net operating loss carryforward of $507,297 from the period prior to Act’s effective date will expire in 2038. The potential tax benefit arising from the net operating loss carryforward of $834,499 from the period following to the Act’s effective date can be carried forward indefinitely within the annual usage limitations. Additionally, the future utilization of the net operating loss carryforward to offset future taxable income is subject to an annual limitation as a result of ownership or business changes that occurred in 2018 and may occur in the future. The Company has not conducted a study to determine the limitations on the utilization of these net operating loss carryforwards. If necessary, the deferred tax assets will be reduced by any carryforward that may not be utilized or expires prior to utilization as a result of such limitations, with a corresponding reduction of the valuation allowance. The Company does not have any uncertain tax positions or events leading to uncertainty in a tax position. The Company’s 2018 and 2017 Corporate Income Tax Returns are subject to Internal Revenue Service examination.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
NOTE 14 - SUBSEQUENT EVENTS	On February 5, 2019, the Company entered into a Service Agreement with PCG Advisory Inc. to provide the Company with the services in the areas of investor relations and strategic communications.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2018
Summary Of Significant Accounting Policies
Basis of Presentation and Principles of Consolidation	The consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (“US GAAP”)and present the consolidated financial statements of the Company and its wholly-owned subsidiaries of which all are inactive except for Rokk3r Ops Inc. All intercompany balances and transactions have been eliminated in the consolidation.
Use of Estimates	The preparation of the consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates for the years ended December 31, 2018 and 2017 include the assumptions used in assessing impairment of investments, allowances on uncollectible accounts receivable, valuation allowances for deferred tax assets, and the fair value of the account receivable, non-cash equity transactions and stock-based compensation.
Cash and Cash Equivalents	For the purposes of the consolidated statements of cash flows, the Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents at December 31, 2018 and 2017, respectively. The Company maintained its cash in various financial institutions during the year ended December 31, 2018. Balances were insured up to Federal Deposit Insurance Corporation limits.
Accounts Receivable	Accounts receivable are stated at their net realizable value. The Company reviews its accounts to estimate losses resulting from the inability of its customer to make required payments. Any required allowance is based on specific analysis of past due accounts and considers historical trends if write-offs. Past due is based on how recently payments have been received from customers. The Company’s collection experience has been favorable reflecting a limited number of customers. As of December 31, 2018, the recorded allowance for bad debt was $148,982 and no allowance was recorded at December 31, 2017.
Revenue Recognition	In accordance with Accounting Standards Codification (“ASC”) 606, Revenue Recognition, The services that are offered are focused on education, consulting, development and growth. The Company provides services to help entrepreneurs and business professionals to innovate and create high growth companies through training, mentorship, and access to our global network of advisors, investors and business builders. Revenue is recognized when the Company performs services pursuant to its agreements with customers and collectability is reasonably assured. If at the outset of an arrangement, the Company determines that collectability is not reasonably assured, revenue is deferred until the earlier of when collectability becomes probable or the receipt of payment. If there is uncertainty as to the customer’s acceptance of the Company’s deliverables, revenue is not recognized until the earlier of receipt of customer acceptance or expiration of the acceptance period. If at the outset of an arrangement, the Company determines that the arrangement fee is not fixed or determinable, revenue is deferred until the arrangement fee becomes estimable, assuming all other revenue recognition criteria have been met. Litigation settlements are accounted for in accordance with the gain contingency provisions of ASC Subtopic 450-30, Gain Contingencies
Fair Value of Financial Instruments	ASC 825, Disclosures about Fair Value of Financial Instruments Fair Value Measurements The carrying amounts reported in the balance sheets for accounts receivable, prepaid expenses, accounts payable, accrued expenses, convertible note payable, note payable and amounts due to parent company approximate their fair market value based on the short-term maturity of these instruments.
Investments	The method of accounting applied to long-term investments, whether consolidated, equity or cost, involves an evaluation of the significant terms of each investment that explicitly grant or suggest evidence of control or influence over the operations of the investee and also includes the identification of any variable interests in which the Company is the primary beneficiary. Investments in businesses that the Company does not control, but in which the Company has the ability to exercise significant influence over operating and financial matters, are accounted for using the equity method. Investments in which the Company does not have the ability to exercise significant influence over operating and financial matters are accounted for using the cost method. Equity and cost method investments are included “Investments” in the accompanying balance sheets. The Company periodically evaluates its equity and cost method investments for impairment due to declines considered to be other than temporary. If the Company determines that a decline in fair value is other than temporary, then a charge to earnings is recorded as an impairment loss in the accompanying statements of operations. Based on an impairment analysis, during the years ended December 31, 2018 and 2017, the Company recorded an impairment loss of nil and $12,489,226, respectively, related to investments with has been included in operating expenses on the accompanying statement of operations (see Note 5).
Convertible Notes with Fixed Rate Conversion Options	The Company may enter into convertible notes, some of which contain, predominantly, fixed rate conversion features, whereby the outstanding principal and accrued interest may be converted by the holder, into common shares at a fixed discount to the market price of the common stock at the time of conversion. This results in a fair value of the convertible note being equal to a fixed monetary amount. The Company records the convertible note liability at its fixed monetary amount by measuring and recording a premium, as applicable, on the Note date with a charge to interest expense in accordance with ASC 480 - Distinguishing Liabilities from Equity
Convertible Debt	In July 2017, the FASB issued Accounting Standards Update (“ASU”) No. 2017-11 Earnings Per Share Distinguishing Liabilities from Equity Derivatives and Hedging Redeemable preferred stock (i.e., redeemable upon the occurrence of an event) and preferred stock that is redeemable (outside the control of the issuer), including those instruments that are redeemable at the option of the holder, are required to be present in mezzanine equity. Mezzanine equity is presented after liabilities and before stockholders’ equity on the balance sheet. The purpose of this classification is to convey that such a security may not be permanently part of equity and could result in a demand for cash or other assets of the entity in the future. Pursuant to ASC 480-10-S99, the Company presents redeemable securities that are classified as mezzanine equity separate from all other stockholders’ equity accounts that are classified as permanent equity (e.g., non-redeemable preferred, common stock, and retained earnings). The Company sold 4,085,938 shares of Series B Preferred for net proceeds of $2,615,000, or $0.64 per preferred share, during the year ended December 31, 2018 which is classified in mezzanine equity under “Redeemable Preferred Stock” (see Note 7).
Redeemable Preferred Stock	Redeemable preferred stock (i.e., redeemable upon the occurrence of an event) and preferred stock that is redeemable (outside the control of the issuer), including those instruments that are redeemable at the option of the holder, are required to be present in mezzanine equity. Mezzanine equity is presented after liabilities and before stockholders’ equity on the balance sheet. The purpose of this classification is to convey that such a security may not be permanently part of equity and could result in a demand for cash or other assets of the entity in the future. Pursuant to ASC 480-10-S99, the Company presents redeemable securities that are classified as mezzanine equity separate from all other stockholders’ equity accounts that are classified as permanent equity (e.g., non-redeemable preferred, common stock, and retained earnings). The Company sold 4,085,938 shares of Series B Preferred for net proceeds of $2,615,000, or $0.64 per preferred share, during the year ended December 31, 2018 which is classified in mezzanine equity under “Redeemable Preferred Stock” (see Note 7).
Basic Loss per Common Share	Basic loss per share is calculated by dividing the net loss allocable to stockholders by the weighted-average number of shares outstanding for the period. Diluted loss per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that shared in the earnings (loss) of the Company. Diluted loss per share is computed by dividing the net loss allocable to stockholders by the weighted average number of shares outstanding for the period and dilutive potential shares outstanding unless such dilutive potential shares would result in anti-dilution. As of December 31, 2018, and 2017, potentially dilutive securities consisted of the following: December 31, 2018 2017 Convertible debt $ — $ 430,000
Stock-Based Compensation	Stock-based compensation is accounted for based on the requirements of ASC 718 – “Compensation –Stock Compensation, ), Improvements to Employee Share-Based Payment Accounting Through March 31, 2018, pursuant to ASC 505-50 – “Equity-Based Payments to Non-Employees ” Improvements to Nonemployee Share-Based Payment Accounting,
Segment Reporting	During the years ended December 31, 2018 and 2017, the Company operated in one business segment.
Recent accounting pronouncements	In November 2018, the FASB issued ASU 2018-18— Collaborative Arrangements 1. Clarify that certain transactions between collaborative arrangement participants should be accounted for as revenue under Topic 606 when the collaborative arrangement participant is a customer in the context of a unit of account. In those situations, all the guidance in Topic 606 should be applied, including recognition, measurement, presentation, and disclosure requirements. 2. Add unit-of-account guidance in Topic 808 to align with the guidance in Topic 606 (that is, a distinct good or service) when an entity is assessing whether the collaborative arrangement or a part of the arrangement is within the scope of Topic 606. 3. Require that in a transaction with a collaborative arrangement participant that is not directly related to sales to third parties, presenting the transaction together with revenue recognized under Topic 606 is precluded if the collaborative arrangement participant is not a customer For public business entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2020, and interim periods within fiscal years beginning after December 15, 2021. Early adoption is permitted, including adoption in any interim period, (1) for public business entities for periods for which financial statements have not yet been issued and (2) for all other entities for periods for which financial statements have not yet been made available for issuance. An entity may not adopt the amendments earlier than its adoption date of Topic 606. The amendments in this Update should be applied retrospectively to the date of initial application of Topic 606. An entity should recognize the cumulative effect of initially applying the amendments as an adjustment to the opening balance of retained earnings of the later of the earliest annual period presented and the annual period that includes the date of the entity’s initial application of Topic 606. An entity may elect to apply the amendments in this Update retrospectively either to all contracts or only to contracts that are not completed at the date of initial application of Topic 606. An entity should disclose its election. An entity may elect to apply the practical expedient for contract modifications that is permitted for entities using the modified retrospective transition method in Topic 606. The Company is currently evaluating the effect on its consolidated financial statements. In February 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-02, Leases
Reclassifications	The Company segregated the legal and bad debt expenses for year ended December 31, 2018 in separate line items in the operating expense section of the accompanying consolidatedstatement of operations and conformed the presentation of the same for the year ended December 31, 2017 for comparative presentation.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Dec. 31, 2018
Summary Of Significant Accounting Policies Tables Abstract
Potentially dilutive securities	December 31, 2018 2017 Convertible debt $ — $ 430,000

PREPAID EXPENSE (Tables)

PREPAID EXPENSE (Tables)	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
PREPAID EXPENSE	Prepaid expenses consisted of the following as of December 31, 2018 and 2017: December 31, 2018 2017 Related party – prepaid consulting fee pursuant to Consulting Services Agreement with ExO $ 250,000 $ — Related party – prepaid consulting fee – parent 175,000 Other 18,953 — $ 443,953 $ —

CONVERTIBLE PROMISSORY NOTE (Ta

CONVERTIBLE PROMISSORY NOTE (Tables)	12 Months Ended
	Dec. 31, 2018
Convertible Promissory Note
Convertible note payable	December 31, 2018 2017 Principal amount $ — $ 430,000 Add: debt premium liability — 110,000 Convertible notes payable, net $ — $ 540,000

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Schedule of Effective Income Tax Rate Reconciliation	Years Ended December 31, 2018 2017 Income tax benefit at U.S. statutory rate of 21% in 2018 and 34% in 2017 $ (716,058 ) $ (12,885,417 ) Income tax benefit – state (187,539 ) (1,894,914 ) Non-deductible expenses 69,098 14,389,886 Effect of change in effective rate — 130,148 Change in valuation allowance 834,499 260,297 Total provision for income tax $ — $ —
Schedule of Deferred Tax Assets	Years Ended December 31, 2018 2017 Net operating loss carryforward $ 1,350,223 $ 507,297 Total deferred tax asset 1,350,223 507,297 Less: Valuation allowance (1,350,223 ) (507,297 ) Net deferred tax asset $ — $ —

ORGANIZATION AND DESCRIPTION _2

ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Narrative) - USD ($)	1 Months Ended	12 Months Ended
	Mar. 20, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 26, 2017
Incorporation of State		Nevada
Incorporation of Date		Sep. 27, 1996
Gain on extinguishment of debt			$ 1,889,938
Principal amount			1,037,632
Accrued interest			$ 852,406
Rokk3r Labs [Member]
Unregistered common stock				74,050,000
Eight Dragons LLC [Member]
Common stock shares returned by related parties				290,500
Ms. Taylor [Member]
Percentage of issued and outstanding shares of common stock				89.41%
Common stock shares returned by related parties				9,710,295
Preferred stock shares returned by related parties				1,000,000
Shares returned by related parties, par value				$ 0.0001
DMJ [Member]
Stock purchase agreement description	Stock Purchase Agreement (the “Agreement”) dated January 26, 2017, with Una Taylor through Eight Dragons Acquisitions, LLC, an entity she controls (the “Buyer”), pursuant to which, among other things, DMJ agreed to sell to the Buyer, and the Buyer agreed to purchase from DMJ, a total of 290,500 shares of common stock owned of record and beneficially by DMJ (the “Purchased Shares”). The Purchased Shares represented, at closing, approximately 80.2% of the Company’s issued and outstanding shares of common stock.

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Summary Of Significant Accounting Policies Details Abstract
Convertible debt		$ 430,000

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Bad debt expense	$ 148,982	$ 5,784
Impairment loss		12,489,226
Cash proceeds from sale of Series B convertible preferred shares	$ 2,615,000
Series B Convertible Preferred Stock [Member]
Preferred Stock, shares issued	4,085,938	0
Preferred stock shares issued, per share	$ 0.64

GOING CONCERN (Details Narrativ

GOING CONCERN (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Going Concern
Net loss	$ (3,409,801)	$ (37,898,285)
Net cash used in operations	(4,015,363)	(830,405)
Accumulated deficit	(74,968,545)	(71,454,325)
Shareholders' equity	1,259,139	369,645	$ (1,865,702)
Cash proceeds from sale of common stock	3,735,380
Cash	2,297,902
Cash proceeds from sale of Series B Convertible Preferred stocks	2,615,000
Net proceeds from sale of common stock	$ 6,350,380

PREPAID EXPENSE (Details)

PREPAID EXPENSE (Details) - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Prepaid Expense
Related party – prepaid consulting fee pursuant to Consulting Services Agreement with ExO	$ 250,000
Related party – prepaid consulting fee – parent	175,000
Other	18,953
Total	$ 443,953

INVESTMENTS (Details Narrative)

INVESTMENTS (Details Narrative) - USD ($)	1 Months Ended			12 Months Ended
	Nov. 19, 2017	Jun. 30, 2017	Apr. 30, 2017	Dec. 31, 2018	Dec. 31, 2017
Stock issued for acquisition, value					$ 102,400
Impairment loss					12,489,226
Common stock value				10,143	9,483
Park Road Solutions [Member]
Common stock price per share		$ 1.28
Common stock shares issued		80,000
Common stock value		$ 102,400
PRTT [Member]
Stock issued for acquisition, shares		3,000,000
Stock issued for acquisition, value		$ 3,840,000
Common stock price per share		$ 1.28
Consideration shares		6,100,000
Stock returned to related party, shares	3,000,000
Stock returned from related party, shares	6,100,000
Rokk3r Labs [Member]
Stock issued for acquisition, shares			9,677,208
Stock issued for acquisition, value			$ 12,386,826
Equity investment			$ 1,000,000	$ 1,000,000	1,000,000
Impairment loss					$ 12,386,826
Ownership percentage			18.72%
Common stock price per share			$ 1.28
Percentage of issued and outstanding shares of common stock			89.41%
Purchase price			$ 1,000,000

CONVERTIBLE PROMISSORY NOTE (De

CONVERTIBLE PROMISSORY NOTE (Details) - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Convertible Promissory Note Details Abstract
Principal amount		$ 430,000
Add: debt premium liability		110,000
Convertible notes payable, net		$ 540,000

CONVERTIBLE PROMISSORY NOTE (_2

CONVERTIBLE PROMISSORY NOTE (Details Narrative) - USD ($)	1 Months Ended			12 Months Ended
	Jun. 15, 2018	Nov. 15, 2017	Apr. 27, 2017	Dec. 31, 2018	Dec. 31, 2017
Debt premium					$ 110,000
Interest expense					110,000
Common stock, value				$ 3,735,380
Accrued interest					852,406
Corporate Note [Member]
Settlement description				result in the beneficial ownership by Firstfire and its affiliates (as calculated pursuant to Section 13(d) of the Exchange Act and the rules and regulations thereunder) at any time of more than 4.99% of the outstanding common stock.
Minimum [Member]
Exercise price				$ 0.64
Firstfire [Member]
Common stock issued for additional consideration			250,000
Penalty payment, description			In the event that the Company fails to pay the principal amount hereof or interest thereon in full on the maturity date, the Company shall be obligated to pay Firstfire an additional $100,000 penalty.
Settlement description			The Firstfire Note was convertible into common stock, at Firstfire’s option, at 75% multiplied by the lowest traded price of the Company common during the ten consecutive trading day period immediately preceding the trading day that the Company receives the Notice of Conversion from the Firstfire.
Interest expense			$ 320,000
Exercise price			$ 1.28
Common stock, value			$ 320,000
Firstfire Global Opportunities [Member] | Securities Purchase Agreements [Member]
Debt face amount			$ 330,000
Maturity date of note			Oct. 27, 2017
Interest rate			1.00%
Settlement Agreement [Member]
Settlement description				no shares of the Company’s common have been issued pursuant to the Settlement Agreement other than 250,000 shares of common stock.
Settlement Agreement [Member] | Firstfire [Member]
Debt face amount		$ 330,000
Interest rate		15.00%
Settlement description	The amount of Settlement Shares includes 250,000 shares of common stock previously issued to Firstfire in 2017 and an additional 750,000 shares to be issued by the Company upon approval of the Firstfire Amendment by the Court.	plus $100,000 as set forth in section 3.1 in the Firstfire Note		(i) 25,000 shares during each consecutive month for a period of three consecutive months which commenced on the first full month after the date the Firstfire Amendment is approved by the Court (the “Order Date”), (ii) 50,000 shares per month for a period of three consecutive months commencing on the fourth month after the Order Date; (iii) 75,000 shares per month for a period of three consecutive months which commenced on the seventh month after the Order Date; and (iv) 100,000 shares each month for a period of three months which commenced on the tenth month after the Order Date. If, however, the dollar value of shares sold by Firstfire during the 18-month lock-up period exceeds $500,000, then the number of shares that may be sold during each month during the six consecutive months after such period shall be limited to 40,000.
Share issuable for settlement	1,000,000
Settlement Agreement [Member] | Firstfire Amendment [Member]
Settlement description				During the year ended December 31, 2018, 750,000 shares of the Company’s common were issued, in addition to the 250,000 shares of common stock issued in 2017
Settlement Agreement [Member] | Firstfire Order [Member]
Settlement description		Firstfire’s option, at a conversion rate equal to 75% multiplied by the lowest traded price of the Company’s common stock during the ten consecutive trading day period immediately preceding the trading day that the Company receives a notice of conversion from Firstfire
Note payable [Member]
Original issuance cost					30,000
Principal amount, increase					100,000
Interest expense					100,000
Convertible Notes Payable [Member]
Accrued interest					$ 13,318

SERIES B REDEEMABLE CONVERTIB_2

SERIES B REDEEMABLE CONVERTIBLE PREFERRED STOCK (Details Narrative) - USD ($)	1 Months Ended	12 Months Ended
	Jul. 26, 2018	Dec. 31, 2018	Dec. 31, 2017
Series B Convertible Preferred Stock [Member]
Preferred shares sold		4,085,938
Cash proceeds from sale of Series B convertible preferred shares		$ 2,615,000
Price per preferred share		$ 0.64
Preferred Stock, shares issued		4,085,938	0
Series B Convertible Preferred Stock [Member]
Preferred Stock, shares issued		104,419
Securities Purchase Agreements [Member] | Accredited Investor [Member] | Series B Convertible Preferred Stock [Member]
Share issuable for settlement	4,687,500
Price per share	$ 0.64
Shares issuable description	An aggregate of 3,906,250 shares will be issued and sold in five monthly tranches of at least 781,250 shares ($500,000) each, which commenced on July 27, 2018, the initial closing date, for an aggregate of $2,500,000. After the earlier of the four-month period after the initial closing date or the sale of 3,906,250 shares and not later than six months after the date of the initial closing, the investor may, but shall not be obligated to, purchase from the Company in a single closing, up to an additional 781,250 shares, not previously sold and never to exceed the number of Series B Preferred, at a price of $0.64 per share.
Security and Pledge Agreement [Member] | Accredited Investor [Member] | Series B Convertible Preferred Stock [Member]
Collateral value	$ 16,000,000
Collateral rights description	(i) the Company has acquired 75% of Rokk3r Labs’ current ownership interests in the aggregate in the entities that make up the reserved equity interests and the Collateral, or (ii) 75% of the shares of Series B Preferred owned by the investor have been converted into the Company’s common stock or have been redeemed by the investor.
Security and Pledge Agreement [Member] | Accredited Investor [Member] | Restricted Common Stock [Member]
Share issuable for settlement	300,000
Share issuable for settlement vesting description	50% remaining balance vesting twenty-four months after the issuance date of the Series B Preferred, so long as at least one investor designee is a member of the advisory board at the time of vesting. In addition, the investor or its affiliates are entitled to, without additional charge, certain corporate educational services the Company provides to its clients.

SHAREHOLDERS_ DEFICIT (Details

SHAREHOLDERS’ DEFICIT (Details Narrative) - USD ($)	Nov. 16, 2018	Nov. 02, 2018	Mar. 07, 2018	Dec. 04, 2017	Dec. 04, 2017	Apr. 12, 2017	Mar. 13, 2017	Jan. 31, 2019	Dec. 26, 2017	Dec. 26, 2017	Nov. 21, 2017	Nov. 19, 2017	Sep. 30, 2017	Jun. 30, 2017	Jun. 30, 2017	Apr. 30, 2017	Apr. 28, 2017	Apr. 27, 2017	Dec. 31, 2018	Dec. 31, 2017	Jul. 26, 2018	Mar. 08, 2018	May 08, 2017
Capital Stock, shares authorized																						150,000,000
Preferred Stock, par value																			$ 0.0001	$ 0.0001
Preferred Stock, shares authorized																			50,000,000	50,000,000
Preferred Stock, shares designate																						1,000,000
Common Stock, par value																			$ 0.0001	$ 0.0001
Common Stock, shares authorized																			500,000,000	500,000,000
Increase in authorized shares																						550,000,000
Stock-based compensation expense																			$ 49,986
Common stock shares cancelled																			2,650,000
Common stock shares issued for services, value																			$ 25,800
Stock issued for debt conversion, Amount																			482,548	$ 1,517,800
Stock issued for convertible debt financing, Amount																				320,000
Investment purchase price																				(1,000,000)
Stock issued to purchase investment, Amount																				12,386,826
Stock issued for acquisition, value																				$ 102,400
Number of shares being cancelled in process																			250,000
Common Stock, Shares issuable																			1,000,000	0
Approved grant of common stock as incentive for employees and contractors, description	In the aggregate amount of not more than $352,000, represented by 550,000 shares, to be vested as per an agreed upon vesting schedule (the “Vesting Date”).
Series A Preferred Stock [Member]
Preferred Stock, par value																			$ 0.0001	$ 0.0001
Preferred Stock, shares authorized																			1,000,000	1,000,000
Preferred Stock, shares issued																			0	0
Preferred Stock, shares outstanding																			0	0
Rokk3r Labs [Member]
Common stock price per share																$ 1.28
Stock issued for acquisition, shares																9,677,208
Stock issued for acquisition, value																$ 12,386,826
Contributed capital					$ 5,000,000
Business acquisition ownership percentage																18.72%
Protect Pharmaceutical Corp [Member]
Common stock price per share														$ 1.28	$ 1.28
Stock issued for acquisition, shares															3,000,000
Stock issued for acquisition, value															$ 3,840,000
Consideration														6,100,000	6,100,000
Park Road Solutions [Member]
Common stock price per share														$ 1.28	$ 1.28
Stock issued for purchase of Park Road Solutions, Shares														80,000
Stock issued for purchase of Park Road Solutions, Amount														$ 102,400
Impairment loss													$ 102,400
Series B Preferred Member
Preferred Stock, shares designate																					4,687,500
Common Stock
Stock-based compensation expense
Common stock shares issued for services																			12,286
Common stock shares issued for services, value																			$ 1
Stock issued for debt conversion, Amount																			$ 75	$ 135
Stock issued upon conversion of debt, Shares																			750,000	1,355,783
Stock issued for convertible debt financing, Shares																				250,000
Stock issued for convertible debt financing, Amount																				$ 25
Stock issued to purchase investment, Shares																				9,677,208
Stock issued to purchase investment, Amount																				$ 968
Stock issued for acquisition, shares																				80,000
Stock issued for acquisition, value																				$ 8
Stock issued for settlement of default and release with Rokk3r Fuel Fund 2, LP pursuant to restructuring agreement, Shares					7,500,000
Firstfire Note [Member]
Common stock price per share																		$ 1.28
Stock issued for convertible debt financing, Shares																		250,000
Stock issued for convertible debt financing, Amount																		$ 320,000
Interest expense																		$ 320,000
DreamFu Angels, LLC [Member]
Stock issued for debt conversion, Amount																$ 1,517,800
Stock issued upon conversion of debt, Shares							1,355,783							1,185,783		1,355,783
Eight Dragons LLC [Member]
Treasury stock, common, shares																	290,500
Sean Young [Member]
Common stock shares cancelled																			1,250,000				1,250,000
Common stock shares reserved for future issuance																			1,250,000
Jordan Fishman [Member]
Common stock shares cancelled																			1,150,000
Una Taylor [Member]
Stock-based compensation expense																	$ 12,429,178
Common stock shares issued for services, value																	$ 12,429,178
Common stock price per share																	$ 1.28
Treasury stock, common, shares																	9,710,295
Common stock shares redeemed																	9,710,295
Una Taylor [Member] | Series A Preferred Stock [Member]
Preferred Stock, shares issued						1,000,000
Stock-based compensation expense						$ 37,500
Common stock shares cancelled									1,000,000	1,000,000
Reversed stock-based compensation expense										$ 37,500
Individuals [Member]
Stock-based compensation expense																	$ 21,143,178
Common stock price per share																	$ 1.28
Stock issued to consultants for services rendered or to be rendered, Shares																	16,518,108
Stock issued to consultants for services rendered or to be rendered, Amount																	$ 21,143,178
2018 Equity Incentive Plan [Member]
Common stock shares reserved for future issuance			15,000,000
Common stock shares reserved for future issuance, description			The shares authorized under the 2018 Equity Incentive Plan automatically increase on January 1, 2019 and each subsequent anniversary through 2028, by an amount equal to the smaller of (a) 3% of the number of shares of common stock issued and outstanding on the immediately preceding December 31, or (b) an amount determined by the Board.
Settlement Agreement [Member] | Firstfire Amendment [Member]
Shares issued during the period																			750,000
Consulting Agreement [Member]
Common stock shares issued for services																			12,286
Common stock shares issued for services, value																			$ 25,800
Subscription Agreements [Member]
Common stock price per share																			$ 0.64
Shares issued during the period																			5,836,532
Cash proceeds from sale of common stock																			$ 3,735,380
Retainer Agreement [Member] | Mr. Ismail [Member]
Common stock granted shares		1,000,000
Services period		4 years
Share based vesting rights percentage		25.00%
Vesting period		Dec. 31, 2019
2017 Omnibus Equity Compensation Plan [Member]
Common stock shares reserved for future issuance						5,000,000
Restructuring Agreement [Member] | Titan Funding [Member] | Subsequent Event [Member]
Owned and Subsidiary percentage								20.00%
Restructuring Agreement [Member] | Una Taylor [Member] | Subsequent Event [Member]
Option acquire common stock shares								4,000,000
Option strike price								$ 0.0001
Term of option exercisable								Common stock, which option will be at a strike price of $0.0001 per share of common stock, and which option will be exercisable for a period of 16 months from the issuance thereof or (ii) 4,000,000 shares of common stock.
Business acquisition ownership percentage								100.00%
Owned and Subsidiary percentage								80.00%
Assignment Agreement [Member] | Unregistered Common Stock [Member] | Rokk3r Labs [Member]
Stock issued for contribution of intangible assets pursuant to restructuring agreement, Shares									74,050,000
Stock Issuance Agreement [Member] | Common Stock | Rokk3r Labs [Member]
Stock issued for settlement of default and release with Rokk3r Fuel Fund 2, LP pursuant to restructuring agreement, Shares				7,500,000
Contributed capital				$ 5,000,000
Rescission Agreements [Member]
Common stock shares cancelled													6,150,000
Cancellation of stock previously issued in exchange for consulting fees													$ 6,592,000
Rescission Agreements [Member] | Protect Pharmaceutical Corp [Member]
Stock issued for acquisition, shares												3,000,000
Stock issued for acquisition, value												$ 3,840,000
Consideration												6,100,000
Equity Purchase Agreement [Member] | Rokk3r Labs [Member]
Common stock price per share																$ 1.28
Investment purchase price																$ 1,000,000
Stock issued to purchase investment, Shares																9,677,208
Stock issued to purchase investment, Amount																$ 12,386,826
Non-controlling member Interest																18.72%
Release Agreements [Member] | Ms. Taylor [Member]
Common stock shares redeemed											9,710,295
Consideration											1

CONCENTRATIONS (Details Narrati

CONCENTRATIONS (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Cash, FDIC insured amount	$ 250,000
Cash	2,297,902
Revenues	2,301,939
Accounts receivable	$ 549,165
One Customer [Member] | Revenue [Member]
Concentration risk, percentage	19.00%
One Customer [Member] | Accounts Receivable [Member]
Concentration risk, percentage	42.00%
Two Customer [Member] | Revenue [Member]
Concentration risk, percentage	12.00%

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	Nov. 15, 2018	Nov. 02, 2018	Mar. 13, 2017	Jun. 30, 2017	Apr. 30, 2017	Dec. 31, 2018	Dec. 31, 2017	Jun. 21, 2018
Cash proceeds from notes payable							$ 1,517,800
Proceeds from parent advances						(16,492)	12,605
Consulting fees - parent						2,701,250
Due to parent company							16,492
Due from parent company						75,138
Prepaid expense – related party						(443,953)
Accrued expense – related party						15,000
Related party – prepaid consulting fee pursuant to Consulting Services Agreement with ExO						250,000
Prepaid expenses - related party						425,000
Collaboration Agreement [Member]
Consulting fees - parent						2,701,250
Prepaid expense – related party						175,000
Trademark License Agreement [Member]
Annual fees	$ 120,000
Consulting Services Agreement [Member]
Related party – prepaid consulting fee pursuant to Consulting Services Agreement with ExO								$ 250,000
Prepaid expenses - related party						250,000
Stock Purchase Agreement [Member] | ExO Foundation Inc.[Member]
Common stock exchange of shares		5,000,000
Ownership interest		50.00%
Safe-T Agreement [Member] | ExO Foundation Inc.[Member]
Proceeds from Issuance of Preferred Stock		$ 5,000,000
Terms of purchase amount description		(a) the value of 5,000,000 shares of the Company’s common stock (the “Purchaser Shares”) to be either (i) the publicly traded price of the Purchaser Shares at the time of the calculation, with the express requirement that if the Purchaser Shares are then trading at over $3.00 then that will be the maximum value of the Purchaser Shares and if the Purchaser Shares are then trading under $0.64 then that will be the minimum value of the Purchaser Shares or (ii) if the Purchaser Shares are not publicly traded at such time, the value of such shares shall be the fair market value, up to but not exceeding $3.00 (referred to as the “Adjusted Value”); (b) with a discount rate of 85% to be applied to the Adjusted Value to determine the final value of the “Purchase Amount.”
Parent [Member]
Proceeds from parent advances						154,700
Repayment of parent advances						$ 229,838
DreamFu Angels, LLC [Member]
Cash proceeds from notes payable			$ 1,517,800
Stock issued upon conversion of debt, Shares			1,355,783	1,185,783	1,355,783
Payment for benefit and direction			$ 1,396,371
Former Chief Executive Officer [Member]
Funds held for the benefit of the Company				$ 121,429

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)	Dec. 04, 2017	Oct. 18, 2018	Mar. 26, 2018	Oct. 31, 2017	Dec. 31, 2018	Nov. 02, 2018	Mar. 09, 2018	May 08, 2017
Balance amount from fuel assignment				$ 68,750
Common stock shares cancelled					2,650,000
Sean Young [Member]
Shares issued								1,250,000
Common stock shares cancelled					1,250,000			1,250,000
Reimbursement for services and expenses			$ 29,000
Common stock reserved for future issuance					1,250,000
Legal obligation, description			The Company believes it has no legal obligation to deliver the 1,250,000 shares of common stock to Mr. Young and disputes his demand for payment.
Jordan Fishman [Member]
Shares issued								1,150,000
Common stock shares cancelled					1,150,000
Third Party [Member]
Debt default amount							$ 35,000
ExO Foundation Inc.[Member] | Stock Purchase Agreement [Member]
Common stock exchange of shares						5,000,000
Common Stock
Stock issued for settlement of default and release with Rokk3r Fuel Fund 2, LP pursuant to restructuring agreement, Shares	7,500,000
Common Stock | On June 1, 2017 [Member]
Stock issued for purchase of Park Road Solutions, Shares					80,000
Rokk3r Labs [Member]
Proceeds from fuel assignment				268,750
Contributed capital	$ 5,000,000
Rokk3r Labs [Member] | Press Media [Member]
Debt default amount		$ 35,000
Interest rate		6.09%
Titan Funding [Member]
Payment for fuel assignment				$ 200,000
Park Road Merger Agreement [Member]
Reimbursement for services and expenses					$ 36,626
Legal obligation, description					The Company believes its right to rescind the Park Road Acquisition, has no legal obligation to deliver the 1,150,000 shares common stock to Mr. Fishman and disputes his other demands.
Park Road Merger Agreement [Member] | Jordan Fishman [Member]
Common stock reserved for future issuance					1,150,000

EMPLOYMENT CONTRACTS AND STOC_2

EMPLOYMENT CONTRACTS AND STOCK COMPENSATION (Details Narrative) - $ / shares	Nov. 02, 2018	Dec. 31, 2018	Dec. 31, 2017
Common Stock, par value		$ 0.0001	$ 0.0001
Common Stock, Shares issuable		1,000,000	0
Retainer Agreement [Member] | Mr. Ismail [Member]
Stock issued compensation for services	1,000,000
Common Stock, par value	$ 0.0001
Services period	4 years
Share based vesting rights percentage	25.00%
Vesting period	Dec. 31, 2022

INCOME TAXES (Details)

INCOME TAXES (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Income Taxes
Income tax benefit at U.S. statutory rate of 21%in 2018 and 34% in 2017	$ (716,058)	$ (12,885,417)
Income tax benefit - state	(187,539)	(1,894,914)
Non-deductible expenses	69,098	14,389,886
Effect of change in effective rate		130,148
Change in valuation allowance	834,499	260,297
Total provision for income tax

INCOME TAXES (Details 1)

INCOME TAXES (Details 1) - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Income Taxes
Net operating loss carry forward	$ 1,350,223	$ 507,297
Total deferred tax assets	1,350,223	507,297
Less: Valuation Allowance	(1,350,223)	(507,297)
Net Deferred Tax Assets

INCOME TAXES (Details Narrative

INCOME TAXES (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Income Taxes Details Narrative Abstract
Net operating loss carry forward	$ 1,350,223	$ 507,297
Operating loss carry-forwards expiration year	2038
Change in valuation allowance	$ 834,499	$ 260,297
Potential tax benefit arising from the net operating loss carryforward	$ 5,095,180